-
1
-
-
0028883178
-
Phospholipid Signaling
-
Divecha, N.; Irvine, R. F. Phospholipid Signaling Cell 1995, 80, 269-278
-
(1995)
Cell
, vol.80
, pp. 269-278
-
-
Divecha, N.1
Irvine, R.F.2
-
2
-
-
0034911881
-
Synthesis and Function of 3-Phosphorylated Inositol Lipids
-
Vanhaesebroeck, B.; Leevers, S. J.; Ahmadi, K.; Timms, J.; Katso, R.; Driscoll, P. C.; Woscholski, R.; Parker, P. J.; Waterfield, M. D. Synthesis and Function of 3-Phosphorylated Inositol Lipids Annu. Rev. Biochem. 2001, 70, 535-602
-
(2001)
Annu. Rev. Biochem.
, vol.70
, pp. 535-602
-
-
Vanhaesebroeck, B.1
Leevers, S.J.2
Ahmadi, K.3
Timms, J.4
Katso, R.5
Driscoll, P.C.6
Woscholski, R.7
Parker, P.J.8
Waterfield, M.D.9
-
3
-
-
0030805703
-
Phosphoinositide 3-Kinases: A Conserved Family of Signal Transducers
-
Vanhaesebroeck, B.; Leevers, S. J.; Panayotou, G.; Waterfield, M. D. Phosphoinositide 3-Kinases: A Conserved Family of Signal Transducers Trends Biochem. Sci. 1997, 22, 267-272
-
(1997)
Trends Biochem. Sci.
, vol.22
, pp. 267-272
-
-
Vanhaesebroeck, B.1
Leevers, S.J.2
Panayotou, G.3
Waterfield, M.D.4
-
4
-
-
0036237488
-
Phosphoinositide Kinases as Enzymes That Produce Versatile Signaling Lipids, Phosphoinositides
-
Kanaho, Y.; Suzuki, T. Phosphoinositide Kinases as Enzymes That Produce Versatile Signaling Lipids, Phosphoinositides J. Biochem. (Tokyo) 2002, 131, 503-509
-
(2002)
J. Biochem. (Tokyo)
, vol.131
, pp. 503-509
-
-
Kanaho, Y.1
Suzuki, T.2
-
5
-
-
0033604577
-
Signaling by Distinct Classes of Phosphoinositide 3-Kinases
-
Vanhaesebroeck, B.; Waterfield, M. D. Signaling by Distinct Classes of Phosphoinositide 3-Kinases Exp. Cell Res. 1999, 253, 239-254
-
(1999)
Exp. Cell Res.
, vol.253
, pp. 239-254
-
-
Vanhaesebroeck, B.1
Waterfield, M.D.2
-
6
-
-
0032497832
-
Structure and Function of Phosphoinositide 3-Kinases
-
Wymann, M. P.; Pirola, L. Structure and Function of Phosphoinositide 3-Kinases Biochim. Biophys. Acta 1998, 1436, 127-150
-
(1998)
Biochim. Biophys. Acta
, vol.1436
, pp. 127-150
-
-
Wymann, M.P.1
Pirola, L.2
-
7
-
-
0026720350
-
Phosphatidylinositol 3-Kinase: Structure and Expression of the 110 Kd Catalytic Subunit
-
Hiles, I. D.; Otsu, M.; Volinia, S.; Fry, M. J.; Gout, I.; Dhand, R.; Panayotou, G.; Ruiz-Larrea, F.; Thompson, A.; Totty, N. F. Phosphatidylinositol 3-Kinase: Structure and Expression of the 110 Kd Catalytic Subunit Cell 1992, 70, 419-429
-
(1992)
Cell
, vol.70
, pp. 419-429
-
-
Hiles, I.D.1
Otsu, M.2
Volinia, S.3
Fry, M.J.4
Gout, I.5
Dhand, R.6
Panayotou, G.7
Ruiz-Larrea, F.8
Thompson, A.9
Totty, N.F.10
-
8
-
-
0031663503
-
Phosphoinositide Kinases
-
Fruman, D. A.; Meyers, R. E.; Cantley, L. C. Phosphoinositide Kinases Annu. Rev. Biochem. 1998, 67, 481-507
-
(1998)
Annu. Rev. Biochem.
, vol.67
, pp. 481-507
-
-
Fruman, D.A.1
Meyers, R.E.2
Cantley, L.C.3
-
9
-
-
0029090212
-
Cloning and Characterization of a G Protein-Activated Human Phosphoinositide-3 Kinase
-
Stoyanov, B.; Volinia, S.; Hanck, T.; Rubio, I.; Loubtchenkov, M.; Malek, D.; Stoyanova, S.; Vanhaesebroeck, B.; Dhand, R.; Nürnberg, B. Cloning and Characterization of a G Protein-Activated Human Phosphoinositide-3 Kinase Science 1995, 269, 690-693
-
(1995)
Science
, vol.269
, pp. 690-693
-
-
Stoyanov, B.1
Volinia, S.2
Hanck, T.3
Rubio, I.4
Loubtchenkov, M.5
Malek, D.6
Stoyanova, S.7
Vanhaesebroeck, B.8
Dhand, R.9
Nürnberg, B.10
-
10
-
-
0030887632
-
The G Beta Gamma Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101
-
Stephens, L. R.; Eguinoa, A.; Erdjument-Bromage, H.; Lui, M.; Cooke, F.; Coadwell, J.; Smrcka, A. S.; Thelen, M.; Cadwallader, K.; Tempst, P.; Hawkins, P. T. The G Beta Gamma Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101 Cell 1997, 89, 105-114
-
(1997)
Cell
, vol.89
, pp. 105-114
-
-
Stephens, L.R.1
Eguinoa, A.2
Erdjument-Bromage, H.3
Lui, M.4
Cooke, F.5
Coadwell, J.6
Smrcka, A.S.7
Thelen, M.8
Cadwallader, K.9
Tempst, P.10
Hawkins, P.T.11
-
11
-
-
15744363780
-
P84, a New Gbetagamma-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110gamma
-
Suire, S.; Coadwell, J.; Ferguson, G. J.; Davidson, K.; Hawkins, P.; Stephens, L. p84, a New Gbetagamma-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110gamma Curr. Biol. 2005, 15, 566-570
-
(2005)
Curr. Biol.
, vol.15
, pp. 566-570
-
-
Suire, S.1
Coadwell, J.2
Ferguson, G.J.3
Davidson, K.4
Hawkins, P.5
Stephens, L.6
-
12
-
-
0033581886
-
Structural Insights into Phosphoinositide 3-Kinase Catalysis and Signalling
-
Walker, E. H.; Perisic, O.; Ried, C.; Stephens, L.; Williams, R. L. Structural Insights into Phosphoinositide 3-Kinase Catalysis and Signalling Nature 1999, 402, 313-320
-
(1999)
Nature
, vol.402
, pp. 313-320
-
-
Walker, E.H.1
Perisic, O.2
Ried, C.3
Stephens, L.4
Williams, R.L.5
-
13
-
-
33744518663
-
Characterization of p87PIKAP, a Novel Regulatory Subunit of Phosphoinositide 3-Kinase Gamma That Is Highly Expressed in Heart and Interacts with PDE3B
-
Voigt, P.; Dorner, M. B.; Schaefer, M. Characterization of p87PIKAP, a Novel Regulatory Subunit of Phosphoinositide 3-Kinase Gamma That Is Highly Expressed in Heart and Interacts with PDE3B J. Biol. Chem. 2006, 281, 9977-9986
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 9977-9986
-
-
Voigt, P.1
Dorner, M.B.2
Schaefer, M.3
-
14
-
-
33746257209
-
The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism
-
Engelman, J. A.; Luo, J.; Cantley, L. C. The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism Nat. Rev. Genet. 2006, 7, 606-619
-
(2006)
Nat. Rev. Genet.
, vol.7
, pp. 606-619
-
-
Engelman, J.A.1
Luo, J.2
Cantley, L.C.3
-
15
-
-
84860206692
-
Regulation and Cellular Functions of Class II Phosphoinositide 3-Kinases
-
Falasca, M.; Maffucci, T. Regulation and Cellular Functions of Class II Phosphoinositide 3-Kinases Biochem. J. 2012, 443, 587-601
-
(2012)
Biochem. J.
, vol.443
, pp. 587-601
-
-
Falasca, M.1
Maffucci, T.2
-
16
-
-
39749141485
-
The Regulation and Function of Class III PI3Ks: Novel Roles for Vps34
-
Backer, J. M. The Regulation and Function of Class III PI3Ks: Novel Roles for Vps34 Biochem. J. 2008, 410, 1-17
-
(2008)
Biochem. J.
, vol.410
, pp. 1-17
-
-
Backer, J.M.1
-
17
-
-
0029156599
-
DNA-Dependent Protein Kinase Catalytic Subunit: A Relative of Phosphatidylinositol 3-Kinase and the Ataxia Telangiectasia Gene Product
-
Hartley, K. O.; Gell, D.; Smith, G. C.; Zhang, H.; Divecha, N.; Connelly, M. A.; Admon, A.; Lees-Miller, S. P.; Anderson, C. W.; Jackson, S. P. DNA-Dependent Protein Kinase Catalytic Subunit: A Relative of Phosphatidylinositol 3-Kinase and the Ataxia Telangiectasia Gene Product Cell 1995, 82, 849-856
-
(1995)
Cell
, vol.82
, pp. 849-856
-
-
Hartley, K.O.1
Gell, D.2
Smith, G.C.3
Zhang, H.4
Divecha, N.5
Connelly, M.A.6
Admon, A.7
Lees-Miller, S.P.8
Anderson, C.W.9
Jackson, S.P.10
-
18
-
-
0036185848
-
The Protein Kinase B/Akt Signalling Pathway in Human Malignancy
-
Nicholson, K. M.; Anderson, N. G. The Protein Kinase B/Akt Signalling Pathway in Human Malignancy Cell. Signalling 2002, 14, 381-395
-
(2002)
Cell. Signalling
, vol.14
, pp. 381-395
-
-
Nicholson, K.M.1
Anderson, N.G.2
-
19
-
-
0032053709
-
Mechanisms and Consequences of Activation of Protein Kinase B/Akt
-
Downward, J. Mechanisms and Consequences of Activation of Protein Kinase B/Akt Curr. Opin. Cell Biol. 1998, 10, 262-267
-
(1998)
Curr. Opin. Cell Biol.
, vol.10
, pp. 262-267
-
-
Downward, J.1
-
20
-
-
0032189381
-
Protein Kinase B (c-Akt): A Multifunctional Mediator of Phosphatidylinositol 3-Kinase Activation
-
Coffer, P. J.; Jin, J.; Woodgett, J. R. Protein Kinase B (c-Akt): A Multifunctional Mediator of Phosphatidylinositol 3-Kinase Activation Biochem. J. 1998, 335 (Part 1) 1-13
-
(1998)
Biochem. J.
, vol.335
, Issue.PART 1
, pp. 1-13
-
-
Coffer, P.J.1
Jin, J.2
Woodgett, J.R.3
-
21
-
-
0036632368
-
The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer
-
Vivanco, I.; Sawyers, C. L. The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer Nat. Rev. Cancer 2002, 2, 489-501
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
22
-
-
1642617693
-
PI3K/Akt Signalling Pathway and Cancer
-
Fresno Vara, J. A.; Casado, E.; de Castro, J.; Cejas, P.; Belda-Iniesta, C.; González-Baron, M. PI3K/Akt Signalling Pathway and Cancer Cancer Treat. Rev. 2004, 30, 193-204
-
(2004)
Cancer Treat. Rev.
, vol.30
, pp. 193-204
-
-
Fresno Vara, J.A.1
Casado, E.2
De Castro, J.3
Cejas, P.4
Belda-Iniesta, C.5
González-Baron, M.6
-
23
-
-
0028360374
-
A Mammalian Protein Targeted by G1-Arresting Rapamycin-Receptor Complex
-
Brown, E. J.; Albers, M. W.; Shin, T. B.; Ichikawa, K.; Keith, C. T.; Lane, W. S.; Schreiber, S. L. A Mammalian Protein Targeted by G1-Arresting Rapamycin-Receptor Complex Nature 1994, 369, 756-758
-
(1994)
Nature
, vol.369
, pp. 756-758
-
-
Brown, E.J.1
Albers, M.W.2
Shin, T.B.3
Ichikawa, K.4
Keith, C.T.5
Lane, W.S.6
Schreiber, S.L.7
-
24
-
-
34347220473
-
Defining the Role of mTOR in Cancer
-
Guertin, D. A.; Sabatini, D. M. Defining the Role of mTOR in Cancer Cancer Cell 2007, 12, 9-22
-
(2007)
Cancer Cell
, vol.12
, pp. 9-22
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
25
-
-
78650510609
-
MTOR: From Growth Signal Integration to Cancer, Diabetes and Ageing
-
Zoncu, R.; Efeyan, A.; Sabatini, D. M. mTOR: From Growth Signal Integration to Cancer, Diabetes and Ageing Nat. Rev. Mol. Cell Biol. 2011, 12, 21-35
-
(2011)
Nat. Rev. Mol. Cell Biol.
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
26
-
-
84859778293
-
MTOR Signaling in Growth Control and Disease
-
Laplante, M.; Sabatini, D. M. mTOR Signaling in Growth Control and Disease Cell 2012, 149, 274-293
-
(2012)
Cell
, vol.149
, pp. 274-293
-
-
Laplante, M.1
Sabatini, D.M.2
-
27
-
-
78751550507
-
PI3K Inhibitors in Cardiovascular Disease
-
Eisenreich, A.; Rauch, U. PI3K Inhibitors in Cardiovascular Disease Cardiovasc. Ther. 2011, 29, 29-36
-
(2011)
Cardiovasc. Ther.
, vol.29
, pp. 29-36
-
-
Eisenreich, A.1
Rauch, U.2
-
28
-
-
33847239467
-
PI3K Delta and PI3K Gamma: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond?
-
Rommel, C.; Camps, M.; Ji, H. PI3K Delta and PI3K Gamma: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond? Nat. Rev. Immunol. 2007, 7, 191-201
-
(2007)
Nat. Rev. Immunol.
, vol.7
, pp. 191-201
-
-
Rommel, C.1
Camps, M.2
Ji, H.3
-
29
-
-
0033856110
-
PTEN, a Unique Tumor Suppressor Gene
-
Dahia, P. L. PTEN, a Unique Tumor Suppressor Gene Endocr. Relat. Cancer 2000, 7, 115-129
-
(2000)
Endocr. Relat. Cancer
, vol.7
, pp. 115-129
-
-
Dahia, P.L.1
-
30
-
-
0037702455
-
The Termination of PI3K Signalling by SHIP1 and SHIP2 Inositol 5-Phosphatases
-
Backers, K.; Blero, D.; Paternotte, N.; Zhang, J.; Erneux, C. The Termination of PI3K Signalling by SHIP1 and SHIP2 Inositol 5-Phosphatases Adv. Enzyme Regul. 2003, 43, 15-28
-
(2003)
Adv. Enzyme Regul.
, vol.43
, pp. 15-28
-
-
Backers, K.1
Blero, D.2
Paternotte, N.3
Zhang, J.4
Erneux, C.5
-
31
-
-
4344684649
-
PTEN Function: How Normal Cells Control It and Tumour Cells Lose It
-
Leslie, N. R.; Downes, C. P. PTEN Function: How Normal Cells Control It and Tumour Cells Lose It Biochem. J. 2004, 382, 1-11
-
(2004)
Biochem. J.
, vol.382
, pp. 1-11
-
-
Leslie, N.R.1
Downes, C.P.2
-
32
-
-
0030936323
-
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
-
Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S. I.; Puc, J.; Miliaresis, C.; Rodgers, L.; McCombie, R.; Bigner, S. H.; Giovanella, B. C.; Ittmann, M.; Tycko, B.; Hibshoosh, H.; Wigler, M. H.; Parsons, R. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer Science 1997, 275, 1943-1947
-
(1997)
Science
, vol.275
, pp. 1943-1947
-
-
Li, J.1
Yen, C.2
Liaw, D.3
Podsypanina, K.4
Bose, S.5
Wang, S.I.6
Puc, J.7
Miliaresis, C.8
Rodgers, L.9
McCombie, R.10
Bigner, S.H.11
Giovanella, B.C.12
Ittmann, M.13
Tycko, B.14
Hibshoosh, H.15
Wigler, M.H.16
Parsons, R.17
-
33
-
-
0032506011
-
The Lipid Phosphatase Activity of PTEN Is Critical for Its Tumor Supressor Function
-
Myers, M. P.; Pass, I.; Batty, I. H.; Van der Kaay, J.; Stolarov, J. P.; Hemmings, B. A.; Wigler, M. H.; Downes, C. P.; Tonks, N. K. The Lipid Phosphatase Activity of PTEN Is Critical for Its Tumor Supressor Function Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 13513-13518
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 13513-13518
-
-
Myers, M.P.1
Pass, I.2
Batty, I.H.3
Van Der Kaay, J.4
Stolarov, J.P.5
Hemmings, B.A.6
Wigler, M.H.7
Downes, C.P.8
Tonks, N.K.9
-
34
-
-
43049128529
-
Tenets of PTEN Tumor Suppression
-
Salmena, L.; Carracedo, A.; Pandolfi, P. P. Tenets of PTEN Tumor Suppression Cell 2008, 133, 403-414
-
(2008)
Cell
, vol.133
, pp. 403-414
-
-
Salmena, L.1
Carracedo, A.2
Pandolfi, P.P.3
-
35
-
-
67649814136
-
PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis
-
Jiang, B.-H.; Liu, L.-Z. PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis Adv. Cancer Res. 2009, 102, 19-65
-
(2009)
Adv. Cancer Res.
, vol.102
, pp. 19-65
-
-
Jiang, B.-H.1
Liu, L.-Z.2
-
36
-
-
20444374445
-
Mutant PIK3CA Promotes Cell Growth and Invasion of Human Cancer Cells
-
Samuels, Y.; Diaz, L. A., Jr; Schmidt-Kittler, O.; Cummins, J. M.; Delong, L.; Cheong, I.; Rago, C.; Huso, D. L.; Lengauer, C.; Kinzler, K. W.; Vogelstein, B.; Velculescu, V. E. Mutant PIK3CA Promotes Cell Growth and Invasion of Human Cancer Cells Cancer Cell 2005, 7, 561-573
-
(2005)
Cancer Cell
, vol.7
, pp. 561-573
-
-
Samuels, Y.1
Diaz, L.A.2
Schmidt-Kittler, O.3
Cummins, J.M.4
Delong, L.5
Cheong, I.6
Rago, C.7
Huso, D.L.8
Lengauer, C.9
Kinzler, K.W.10
Vogelstein, B.11
Velculescu, V.E.12
-
37
-
-
11144358645
-
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
-
Samuels, Y.; Wang, Z.; Bardelli, A.; Silliman, N.; Ptak, J.; Szabo, S.; Yan, H.; Gazdar, A.; Powell, S. M.; Riggins, G. J.; Willson, J. K. V.; Markowitz, S.; Kinzler, K. W.; Vogelstein, B.; Velculescu, V. E. High Frequency of Mutations of the PIK3CA Gene in Human Cancers Science 2004, 304, 554
-
(2004)
Science
, vol.304
, pp. 554
-
-
Samuels, Y.1
Wang, Z.2
Bardelli, A.3
Silliman, N.4
Ptak, J.5
Szabo, S.6
Yan, H.7
Gazdar, A.8
Powell, S.M.9
Riggins, G.J.10
Willson, J.K.V.11
Markowitz, S.12
Kinzler, K.W.13
Vogelstein, B.14
Velculescu, V.E.15
-
38
-
-
33645717035
-
Human Tumor Mutants in the p110alpha Subunit of PI3K
-
Liu, Z.; Roberts, T. M. Human Tumor Mutants in the p110alpha Subunit of PI3K Cell Cycle 2006, 5, 675-677
-
(2006)
Cell Cycle
, vol.5
, pp. 675-677
-
-
Liu, Z.1
Roberts, T.M.2
-
39
-
-
65949092291
-
PIK3CA Mutations in Human Solid Tumors: Role in Sensitivity to Various Therapeutic Approaches
-
Ligresti, G.; Militello, L.; Steelman, L. S.; Cavallaro, A.; Basile, F.; Nicoletti, F.; Stivala, F.; McCubrey, J. A.; Libra, M. PIK3CA Mutations in Human Solid Tumors: Role in Sensitivity to Various Therapeutic Approaches Cell Cycle 2009, 8, 1352-1358
-
(2009)
Cell Cycle
, vol.8
, pp. 1352-1358
-
-
Ligresti, G.1
Militello, L.2
Steelman, L.S.3
Cavallaro, A.4
Basile, F.5
Nicoletti, F.6
Stivala, F.7
McCubrey, J.A.8
Libra, M.9
-
41
-
-
0035886016
-
The Phosphatidylinositol 3-Kinase p85alpha Gene Is an Oncogene in Human Ovarian and Colon Tumors
-
Philp, A. J.; Campbell, I. G.; Leet, C.; Vincan, E.; Rockman, S. P.; Whitehead, R. H.; Thomas, R. J.; Phillips, W. A. The Phosphatidylinositol 3-Kinase p85alpha Gene Is an Oncogene in Human Ovarian and Colon Tumors Cancer Res. 2001, 61, 7426-7429
-
(2001)
Cancer Res.
, vol.61
, pp. 7426-7429
-
-
Philp, A.J.1
Campbell, I.G.2
Leet, C.3
Vincan, E.4
Rockman, S.P.5
Whitehead, R.H.6
Thomas, R.J.7
Phillips, W.A.8
-
42
-
-
0026667730
-
AKT2, a Putative Oncogene Encoding a Member of a Subfamily of Protein-Serine/Threonine Kinases, Is Amplified in Human Ovarian Carcinomas
-
Cheng, J. Q.; Godwin, A. K.; Bellacosa, A.; Taguchi, T.; Franke, T. F.; Hamilton, T. C.; Tsichlis, P. N.; Testa, J. R. AKT2, a Putative Oncogene Encoding a Member of a Subfamily of Protein-Serine/Threonine Kinases, Is Amplified in Human Ovarian Carcinomas Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 9267-9271
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 9267-9271
-
-
Cheng, J.Q.1
Godwin, A.K.2
Bellacosa, A.3
Taguchi, T.4
Franke, T.F.5
Hamilton, T.C.6
Tsichlis, P.N.7
Testa, J.R.8
-
43
-
-
0036185848
-
The Protein Kinase B/Akt Signalling Pathway in Human Malignancy
-
Nicholson, K. M.; Anderson, N. G. The Protein Kinase B/Akt Signalling Pathway in Human Malignancy Cell. Signalling 2002, 14, 381-395
-
(2002)
Cell. Signalling
, vol.14
, pp. 381-395
-
-
Nicholson, K.M.1
Anderson, N.G.2
-
44
-
-
0037269497
-
Possible Dominant-Negative Mutation of the SHIP Gene in Acute Myeloid Leukemia
-
Luo, J.-M.; Yoshida, H.; Komura, S.; Ohishi, N.; Pan, L.; Shigeno, K.; Hanamura, I.; Miura, K.; Iida, S.; Ueda, R.; Naoe, T.; Akao, Y.; Ohno, R.; Ohnishi, K. Possible Dominant-Negative Mutation of the SHIP Gene in Acute Myeloid Leukemia Leukemia 2003, 17, 1-8
-
(2003)
Leukemia
, vol.17
, pp. 1-8
-
-
Luo, J.-M.1
Yoshida, H.2
Komura, S.3
Ohishi, N.4
Pan, L.5
Shigeno, K.6
Hanamura, I.7
Miura, K.8
Iida, S.9
Ueda, R.10
Naoe, T.11
Akao, Y.12
Ohno, R.13
Ohnishi, K.14
-
45
-
-
79960237399
-
Therapeutic Resistance Resulting from Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways
-
McCubrey, J. A.; Steelman, L. S.; Kempf, C. R.; Chappell, W. H.; Abrams, S. L.; Stivala, F.; Malaponte, G.; Nicoletti, F.; Libra, M.; Bäsecke, J.; Maksimovic-Ivanic, D.; Mijatovic, S.; Montalto, G.; Cervello, M.; Cocco, L.; Martelli, A. M. Therapeutic Resistance Resulting from Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways J. Cell. Physiol. 2011, 226, 2762-2781
-
(2011)
J. Cell. Physiol.
, vol.226
, pp. 2762-2781
-
-
McCubrey, J.A.1
Steelman, L.S.2
Kempf, C.R.3
Chappell, W.H.4
Abrams, S.L.5
Stivala, F.6
Malaponte, G.7
Nicoletti, F.8
Libra, M.9
Bäsecke, J.10
Maksimovic-Ivanic, D.11
Mijatovic, S.12
Montalto, G.13
Cervello, M.14
Cocco, L.15
Martelli, A.M.16
-
46
-
-
84868628069
-
Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response
-
McCubrey, J. A.; Steelman, L. S.; Chappell, W. H.; Abrams, S. L.; Montalto, G.; Cervello, M.; Nicoletti, F.; Fagone, P.; Malaponte, G.; Mazzarino, M. C.; Candido, S.; Libra, M.; Bäsecke, J.; Mijatovic, S.; Maksimovic-Ivanic, D.; Milella, M.; Tafuri, A.; Cocco, L.; Evangelisti, C.; Chiarini, F.; Martelli, A. M. Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response Oncotarget 2012, 3, 954-987
-
(2012)
Oncotarget
, vol.3
, pp. 954-987
-
-
McCubrey, J.A.1
Steelman, L.S.2
Chappell, W.H.3
Abrams, S.L.4
Montalto, G.5
Cervello, M.6
Nicoletti, F.7
Fagone, P.8
Malaponte, G.9
Mazzarino, M.C.10
Candido, S.11
Libra, M.12
Bäsecke, J.13
Mijatovic, S.14
Maksimovic-Ivanic, D.15
Milella, M.16
Tafuri, A.17
Cocco, L.18
Evangelisti, C.19
Chiarini, F.20
Martelli, A.M.21
more..
-
47
-
-
84875748505
-
Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
-
Cidado, J.; Park, B. H. Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy J. Mammary Gland Biol. Neoplasia 2012, 17, 205-216
-
(2012)
J. Mammary Gland Biol. Neoplasia
, vol.17
, pp. 205-216
-
-
Cidado, J.1
Park, B.H.2
-
48
-
-
84876848854
-
Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
-
Grunt, T. W.; Mariani, G. L. Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling Curr. Cancer Drug Targets 2013, 13, 188-204
-
(2013)
Curr. Cancer Drug Targets
, vol.13
, pp. 188-204
-
-
Grunt, T.W.1
Mariani, G.L.2
-
49
-
-
84868528894
-
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
-
Slomovitz, B. M.; Coleman, R. L. The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer Clin. Cancer Res. 2012, 18, 5856-5864
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 5856-5864
-
-
Slomovitz, B.M.1
Coleman, R.L.2
-
50
-
-
84881479778
-
Targeting the PI3K/AKT/mTOR Signaling Pathway in Glioblastoma: Novel Therapeutic Agents and Advances in Understanding
-
Sami, A.; Karsy, M. Targeting the PI3K/AKT/mTOR Signaling Pathway in Glioblastoma: Novel Therapeutic Agents and Advances in Understanding Tumour Biol. 2013, 34, 1991-2002
-
(2013)
Tumour Biol.
, vol.34
, pp. 1991-2002
-
-
Sami, A.1
Karsy, M.2
-
51
-
-
84878437544
-
PI3K/Akt/mTOR Pathway Inhibitors in the Therapy of Pancreatic Neuroendocrine Tumors
-
Wolin, E. M. PI3K/Akt/mTOR Pathway Inhibitors in the Therapy of Pancreatic Neuroendocrine Tumors Cancer Lett. 2013, 335, 1-8
-
(2013)
Cancer Lett.
, vol.335
, pp. 1-8
-
-
Wolin, E.M.1
-
52
-
-
23144467910
-
An Expanding Role for mTOR in Cancer
-
Guertin, D. A.; Sabatini, D. M. An Expanding Role for mTOR in Cancer Trends Mol. Med. 2005, 11, 353-361
-
(2005)
Trends Mol. Med.
, vol.11
, pp. 353-361
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
53
-
-
84882818868
-
The PIKK Family of Protein Kinases
-
In; Elsevier Academic Press: New York, Vol.
-
Smith, G. C. M.; Jackson, S. P. The PIKK Family of Protein Kinases. In Handbook of Cell Signaling; Elsevier Academic Press: New York, 2010; Vol. 2; pp 575-580.
-
(2010)
Handbook of Cell Signaling
, vol.2
, pp. 575-580
-
-
Smith, G.C.M.1
Jackson, S.P.2
-
54
-
-
84875423827
-
The ATM Protein Kinase: Regulating the Cellular Response to Genotoxic Stress, and More
-
Shiloh, Y.; Ziv, Y. The ATM Protein Kinase: Regulating the Cellular Response to Genotoxic Stress, and More Nat. Rev. Mol. Cell Biol. 2013, 14, 197-210
-
(2013)
Nat. Rev. Mol. Cell Biol.
, vol.14
, pp. 197-210
-
-
Shiloh, Y.1
Ziv, Y.2
-
55
-
-
77956401853
-
The DNA-Dependent Protein Kinase (DNA-PK): More Than Just a Case of Making Ends Meet?
-
Hill, R.; Lee, P. W. K. The DNA-Dependent Protein Kinase (DNA-PK): More Than Just a Case of Making Ends Meet? Cell Cycle 2010, 9, 3460-3469
-
(2010)
Cell Cycle
, vol.9
, pp. 3460-3469
-
-
Hill, R.1
Lee, P.W.K.2
-
56
-
-
1042292696
-
ATM and ATR: Sensing DNA Damage
-
Yang, J.; Xu, Z.-P.; Huang, Y.; Hamrick, H. E.; Duerksen-Hughes, P. J.; Yu, Y.-N. ATM and ATR: Sensing DNA Damage World J. Gastroenterol. 2004, 10, 155-160
-
(2004)
World J. Gastroenterol.
, vol.10
, pp. 155-160
-
-
Yang, J.1
Xu, Z.-P.2
Huang, Y.3
Hamrick, H.E.4
Duerksen-Hughes, P.J.5
Yu, Y.-N.6
-
57
-
-
0035093737
-
DNA Double-Strand Breaks: Signaling, Repair and the Cancer Connection
-
Khanna, K. K.; Jackson, S. P. DNA Double-Strand Breaks: Signaling, Repair and the Cancer Connection Nat. Genet. 2001, 27, 247-254
-
(2001)
Nat. Genet.
, vol.27
, pp. 247-254
-
-
Khanna, K.K.1
Jackson, S.P.2
-
58
-
-
77955943918
-
Ataxia-Telangiectasia Mutated Kinase (ATM) as a Central Regulator of Radiation-Induced DNA Damage Response
-
Tichy, A.; Vávrová, J.; Pejchal, J.; Rezácová, M. Ataxia-Telangiectasia Mutated Kinase (ATM) as a Central Regulator of Radiation-Induced DNA Damage Response Acta Medica (Hradec Kralove, Czech Repub.) 2010, 53, 13-17
-
(2010)
Acta Medica (Hradec Kralove, Czech Repub.)
, vol.53
, pp. 13-17
-
-
Tichy, A.1
Vávrová, J.2
Pejchal, J.3
Rezácová, M.4
-
59
-
-
0035253615
-
ATM and ATR: Networking Cellular Responses to DNA Damage
-
Shiloh, Y. ATM and ATR: Networking Cellular Responses to DNA Damage Curr. Opin. Genet. Dev. 2001, 11, 71-77
-
(2001)
Curr. Opin. Genet. Dev.
, vol.11
, pp. 71-77
-
-
Shiloh, Y.1
-
60
-
-
70350504453
-
The DNA-Damage Response in Human Biology and Disease
-
Jackson, S. P.; Bartek, J. The DNA-Damage Response in Human Biology and Disease Nature 2009, 461, 1071-1078
-
(2009)
Nature
, vol.461
, pp. 1071-1078
-
-
Jackson, S.P.1
Bartek, J.2
-
61
-
-
38049155945
-
Regulation of DNA Double-Strand Break Repair Pathway Choice
-
Shrivastav, M.; De Haro, L. P.; Nickoloff, J. A. Regulation of DNA Double-Strand Break Repair Pathway Choice Cell Res. 2008, 18, 134-147
-
(2008)
Cell Res.
, vol.18
, pp. 134-147
-
-
Shrivastav, M.1
De Haro, L.P.2
Nickoloff, J.A.3
-
62
-
-
62349103878
-
DNA Repair in Mammalian Cells: DNA Double-Strand Break Repair: How to Fix a Broken Relationship
-
Pardo, B.; Gomez-González, B.; Aguilera, A. DNA Repair in Mammalian Cells: DNA Double-Strand Break Repair: How To Fix a Broken Relationship Cell. Mol. Life Sci. 2009, 66, 1039-1056
-
(2009)
Cell. Mol. Life Sci.
, vol.66
, pp. 1039-1056
-
-
Pardo, B.1
Gomez-González, B.2
Aguilera, A.3
-
63
-
-
0034031137
-
DNA Double Strand Break Repair in Mammalian Cells
-
Karran, P. DNA Double Strand Break Repair in Mammalian Cells Curr. Opin. Genet. Dev. 2000, 10, 144-150
-
(2000)
Curr. Opin. Genet. Dev.
, vol.10
, pp. 144-150
-
-
Karran, P.1
-
64
-
-
67650578601
-
DNA-PKcs and ATM Co-Regulate DNA Double-Strand Break Repair
-
Shrivastav, M.; Miller, C. A.; De Haro, L. P.; Durant, S. T.; Chen, B. P. C.; Chen, D. J.; Nickoloff, J. A. DNA-PKcs and ATM Co-Regulate DNA Double-Strand Break Repair DNA Repair 2009, 8, 920-929
-
(2009)
DNA Repair
, vol.8
, pp. 920-929
-
-
Shrivastav, M.1
Miller, C.A.2
De Haro, L.P.3
Durant, S.T.4
Chen, B.P.C.5
Chen, D.J.6
Nickoloff, J.A.7
-
65
-
-
0035833552
-
Structure of the Ku Heterodimer Bound to DNA and Its Implications for Double-Strand Break Repair
-
Walker, J. R.; Corpina, R. A.; Goldberg, J. Structure of the Ku Heterodimer Bound to DNA and Its Implications for Double-Strand Break Repair Nature 2001, 412, 607-614
-
(2001)
Nature
, vol.412
, pp. 607-614
-
-
Walker, J.R.1
Corpina, R.A.2
Goldberg, J.3
-
66
-
-
78649446475
-
A Structural Model for Regulation of NHEJ by DNA-PKcs Autophosphorylation
-
Dobbs, T. A.; Tainer, J. A.; Lees-Miller, S. P. A Structural Model for Regulation of NHEJ by DNA-PKcs Autophosphorylation DNA Repair 2010, 9, 1307-1314
-
(2010)
DNA Repair
, vol.9
, pp. 1307-1314
-
-
Dobbs, T.A.1
Tainer, J.A.2
Lees-Miller, S.P.3
-
67
-
-
73849140503
-
Crystal Structure of DNA-PKcs Reveals a Large Open-Ring Cradle Comprised of HEAT Repeats
-
Sibanda, B. L.; Chirgadze, D. Y.; Blundell, T. L. Crystal Structure of DNA-PKcs Reveals a Large Open-Ring Cradle Comprised of HEAT Repeats Nature 2010, 463, 118-121
-
(2010)
Nature
, vol.463
, pp. 118-121
-
-
Sibanda, B.L.1
Chirgadze, D.Y.2
Blundell, T.L.3
-
68
-
-
77953091045
-
Structure of the Human mTOR Complex i and Its Implications for Rapamycin Inhibition
-
Yip, C. K.; Murata, K.; Walz, T.; Sabatini, D. M.; Kang, S. A. Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition Mol. Cell 2010, 38, 768-774
-
(2010)
Mol. Cell
, vol.38
, pp. 768-774
-
-
Yip, C.K.1
Murata, K.2
Walz, T.3
Sabatini, D.M.4
Kang, S.A.5
-
69
-
-
0037178786
-
MTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex That Signals to the Cell Growth Machinery
-
Kim, D.-H.; Sarbassov, D. D.; Ali, S. M.; King, J. E.; Latek, R. R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D. M. mTOR Interacts with Raptor To Form a Nutrient-Sensitive Complex That Signals to the Cell Growth Machinery Cell 2002, 110, 163-175
-
(2002)
Cell
, vol.110
, pp. 163-175
-
-
Kim, D.-H.1
Sarbassov, D.D.2
Ali, S.M.3
King, J.E.4
Latek, R.R.5
Erdjument-Bromage, H.6
Tempst, P.7
Sabatini, D.M.8
-
70
-
-
0030218023
-
Ataxia-Telangiectasia: A Multifaceted Genetic Disorder Associated with Defective Signal Transduction
-
Lavin, M. F.; Shiloh, Y. Ataxia-Telangiectasia: A Multifaceted Genetic Disorder Associated with Defective Signal Transduction Curr. Opin. Immunol. 1996, 8, 459-464
-
(1996)
Curr. Opin. Immunol.
, vol.8
, pp. 459-464
-
-
Lavin, M.F.1
Shiloh, Y.2
-
71
-
-
0032775680
-
ATM: The Product of the Gene Mutated in Ataxia-Telangiectasia
-
Lavin, M. F. ATM: The Product of the Gene Mutated in Ataxia-Telangiectasia Int. J. Biochem. Cell Biol. 1999, 31, 735-740
-
(1999)
Int. J. Biochem. Cell Biol.
, vol.31
, pp. 735-740
-
-
Lavin, M.F.1
-
72
-
-
0017819141
-
Unrepaired DNA Strand Breaks in Irradiated Ataxia Telangiectasia Lymphocytes Suggested from Cytogenetic Observations
-
Taylor, A. M. Unrepaired DNA Strand Breaks in Irradiated Ataxia Telangiectasia Lymphocytes Suggested from Cytogenetic Observations Mutat. Res. 1978, 50, 407-418
-
(1978)
Mutat. Res.
, vol.50
, pp. 407-418
-
-
Taylor, A.M.1
-
73
-
-
15844426692
-
ATM-Deficient Mice: A Paradigm of Ataxia Telangiectasia
-
Barlow, C.; Hirotsune, S.; Paylor, R.; Liyanage, M.; Eckhaus, M.; Collins, F.; Shiloh, Y.; Crawley, J. N.; Ried, T.; Tagle, D.; Wynshaw-Boris, A. ATM-Deficient Mice: A Paradigm of Ataxia Telangiectasia Cell 1996, 86, 159-171
-
(1996)
Cell
, vol.86
, pp. 159-171
-
-
Barlow, C.1
Hirotsune, S.2
Paylor, R.3
Liyanage, M.4
Eckhaus, M.5
Collins, F.6
Shiloh, Y.7
Crawley, J.N.8
Ried, T.9
Tagle, D.10
Wynshaw-Boris, A.11
-
74
-
-
0031663617
-
ATM: From Gene to Function
-
Rotman, G.; Shiloh, Y. ATM: From Gene to Function Hum. Mol. Genet. 1998, 7, 1555-1563
-
(1998)
Hum. Mol. Genet.
, vol.7
, pp. 1555-1563
-
-
Rotman, G.1
Shiloh, Y.2
-
75
-
-
0042674256
-
G2 Arrest in Response to Topoisomerase II Inhibitors: The Role of p53
-
Clifford, B.; Beljin, M.; Stark, G. R.; Taylor, W. R. G2 Arrest in Response to Topoisomerase II Inhibitors: The Role of p53 Cancer Res. 2003, 63, 4074-4081
-
(2003)
Cancer Res.
, vol.63
, pp. 4074-4081
-
-
Clifford, B.1
Beljin, M.2
Stark, G.R.3
Taylor, W.R.4
-
76
-
-
0038011619
-
Loss of ATM Sensitises p53-Deficient Cells to Topoisomerase Poisons and Antimetabolites
-
Fedier, A.; Schlamminger, M.; Schwarz, V. A.; Haller, U.; Howell, S. B.; Fink, D. Loss of ATM Sensitises p53-Deficient Cells to Topoisomerase Poisons and Antimetabolites Ann. Oncol. 2003, 14, 938-945
-
(2003)
Ann. Oncol.
, vol.14
, pp. 938-945
-
-
Fedier, A.1
Schlamminger, M.2
Schwarz, V.A.3
Haller, U.4
Howell, S.B.5
Fink, D.6
-
77
-
-
0038418869
-
Chk1 and Chk2 Kinases in Checkpoint Control and Cancer
-
Bartek, J.; Lukas, J. Chk1 and Chk2 Kinases in Checkpoint Control and Cancer Cancer Cell 2003, 3, 421-429
-
(2003)
Cancer Cell
, vol.3
, pp. 421-429
-
-
Bartek, J.1
Lukas, J.2
-
78
-
-
1542725073
-
Targeting the Checkpoint Kinases: Chemosensitization versus Chemoprotection
-
Zhou, B.-B. S.; Bartek, J. Targeting the Checkpoint Kinases: Chemosensitization versus Chemoprotection Nat. Rev. Cancer 2004, 4, 216-225
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 216-225
-
-
Zhou, B.-B.S.1
Bartek, J.2
-
79
-
-
38949147038
-
G2 Checkpoint Abrogation and Checkpoint Kinase-1 Targeting in the Treatment of Cancer
-
Bucher, N.; Britten, C. D. G2 Checkpoint Abrogation and Checkpoint Kinase-1 Targeting in the Treatment of Cancer Br. J. Cancer 2008, 98, 523-528
-
(2008)
Br. J. Cancer
, vol.98
, pp. 523-528
-
-
Bucher, N.1
Britten, C.D.2
-
80
-
-
10644269399
-
Poly(ADP-ribose) Polymerase Inhibitors as Potential Chemotherapeutic Agents
-
Bryant, H. E.; Helleday, T. Poly(ADP-ribose) Polymerase Inhibitors as Potential Chemotherapeutic Agents Biochem. Soc. Trans. 2004, 32, 959-961
-
(2004)
Biochem. Soc. Trans.
, vol.32
, pp. 959-961
-
-
Bryant, H.E.1
Helleday, T.2
-
81
-
-
84868221110
-
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
-
Murai, J.; Huang, S. N.; Das, B. B.; Renaud, A.; Zhang, Y.; Doroshow, J. H.; Ji, J.; Takeda, S.; Pommier, Y. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors Cancer Res. 2012, 72, 5588-5599
-
(2012)
Cancer Res.
, vol.72
, pp. 5588-5599
-
-
Murai, J.1
Huang, S.N.2
Das, B.B.3
Renaud, A.4
Zhang, Y.5
Doroshow, J.H.6
Ji, J.7
Takeda, S.8
Pommier, Y.9
-
82
-
-
84865737317
-
Role of PARP Inhibitors in Cancer Biology and Therapy
-
Davar, D.; Beumer, J. H.; Hamieh, L.; Tawbi, H. Role of PARP Inhibitors in Cancer Biology and Therapy Curr. Med. Chem. 2012, 19, 3907-3921
-
(2012)
Curr. Med. Chem.
, vol.19
, pp. 3907-3921
-
-
Davar, D.1
Beumer, J.H.2
Hamieh, L.3
Tawbi, H.4
-
83
-
-
31544464704
-
Targeted Modulation of MGMT: Clinical Implications
-
Liu, L.; Gerson, S. L. Targeted Modulation of MGMT: Clinical Implications Clin. Cancer Res. 2006, 12, 328-331
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 328-331
-
-
Liu, L.1
Gerson, S.L.2
-
84
-
-
78149469118
-
Targeting O 6-Methylguanine-DNA Methyltransferase with Specific Inhibitors as a Strategy in Cancer Therapy
-
Kaina, B.; Margison, G. P.; Christmann, M. Targeting O 6-Methylguanine-DNA Methyltransferase with Specific Inhibitors as a Strategy in Cancer Therapy Cell. Mol. Life Sci. 2010, 67, 3663-3681
-
(2010)
Cell. Mol. Life Sci.
, vol.67
, pp. 3663-3681
-
-
Kaina, B.1
Margison, G.P.2
Christmann, M.3
-
85
-
-
39749166975
-
DNA Repair Pathways as Targets for Cancer Therapy
-
Helleday, T.; Petermann, E.; Lundin, C.; Hodgson, B.; Sharma, R. A. DNA Repair Pathways as Targets for Cancer Therapy Nat. Rev. Cancer 2008, 8, 193-204
-
(2008)
Nat. Rev. Cancer
, vol.8
, pp. 193-204
-
-
Helleday, T.1
Petermann, E.2
Lundin, C.3
Hodgson, B.4
Sharma, R.A.5
-
86
-
-
27844511579
-
DNA Repair Inhibition: A Selective Tumour Targeting Strategy
-
Madhusudan, S.; Hickson, I. D. DNA Repair Inhibition: A Selective Tumour Targeting Strategy Trends Mol. Med. 2005, 11, 503-511
-
(2005)
Trends Mol. Med.
, vol.11
, pp. 503-511
-
-
Madhusudan, S.1
Hickson, I.D.2
-
87
-
-
34547754492
-
Targeting DNA Repair as a Promising Approach in Cancer Therapy
-
Damia, G.; DIncalci, M. Targeting DNA Repair as a Promising Approach in Cancer Therapy Eur. J. Cancer 2007, 43, 1791-1801
-
(2007)
Eur. J. Cancer
, vol.43
, pp. 1791-1801
-
-
Damia, G.1
Dincalci, M.2
-
88
-
-
84874107696
-
Targeting DNA Repair Mechanisms in Cancer
-
Furgason, J. M.; Bahassi, E. M. Targeting DNA Repair Mechanisms in Cancer Pharmacol. Ther. 2013, 137, 298-308
-
(2013)
Pharmacol. Ther.
, vol.137
, pp. 298-308
-
-
Furgason, J.M.1
Bahassi, E.M.2
-
89
-
-
2642567204
-
DNA-Dependent Protein Kinase Inhibitors as Drug Candidates for the Treatment of Cancer
-
Kashishian, A.; Douangpanya, H.; Clark, D.; Schlachter, S. T.; Eary, C. T.; Schiro, J. G.; Huang, H.; Burgess, L. E.; Kesicki, E. A.; Halbrook, J. DNA-Dependent Protein Kinase Inhibitors as Drug Candidates for the Treatment of Cancer Mol. Cancer Ther. 2003, 2, 1257-1264
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 1257-1264
-
-
Kashishian, A.1
Douangpanya, H.2
Clark, D.3
Schlachter, S.T.4
Eary, C.T.5
Schiro, J.G.6
Huang, H.7
Burgess, L.E.8
Kesicki, E.A.9
Halbrook, J.10
-
90
-
-
84878589114
-
DNA-Dependent Protein Kinase and Its Inhibition in Support of Radiotherapy
-
Novotná, E.; Tichy, A.; Pejchal, J.; Lukásová, E.; Salovská, B.; Vávrová, J. DNA-Dependent Protein Kinase and Its Inhibition in Support of Radiotherapy Int. J. Radiat. Biol. 2013, 89, 416-423
-
(2013)
Int. J. Radiat. Biol.
, vol.89
, pp. 416-423
-
-
Novotná, E.1
Tichy, A.2
Pejchal, J.3
Lukásová, E.4
Salovská, B.5
Vávrová, J.6
-
91
-
-
0030814125
-
Radiosensitization of Human Tumor Cells by the Phosphatidylinositol 3-Kinase Inhibitors Wortmannin and 3 Correlates with Inhibition of DNA-Dependent Protein Kinase and Prolonged G(2)-M Delay
-
Rosenzweig, K. E.; Youmell, M. B.; Palayoor, S. T.; Price, B. D. Radiosensitization of Human Tumor Cells by the Phosphatidylinositol 3-Kinase Inhibitors Wortmannin and 3 Correlates with Inhibition of DNA-Dependent Protein Kinase and Prolonged G(2)-M Delay Clin. Cancer Res. 1997, 3, 1149-1156
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 1149-1156
-
-
Rosenzweig, K.E.1
Youmell, M.B.2
Palayoor, S.T.3
Price, B.D.4
-
92
-
-
31544444486
-
Phosphatidylinositol 3-Kinase Inhibition by 3 Radiosensitizes Human Cervical Cancer Cell Lines
-
Lee, C. M.; Fuhrman, C. B.; Planelles, V.; Peltier, M. R.; Gaffney, D. K.; Soisson, A. P.; Dodson, M. K.; Tolley, H. D.; Green, C. L.; Zempolich, K. A. Phosphatidylinositol 3-Kinase Inhibition by 3 Radiosensitizes Human Cervical Cancer Cell Lines Clin. Cancer Res. 2006, 12, 250-256
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 250-256
-
-
Lee, C.M.1
Fuhrman, C.B.2
Planelles, V.3
Peltier, M.R.4
Gaffney, D.K.5
Soisson, A.P.6
Dodson, M.K.7
Tolley, H.D.8
Green, C.L.9
Zempolich, K.A.10
-
93
-
-
25444497278
-
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
-
Kaelin, W. G., Jr. The Concept of Synthetic Lethality in the Context of Anticancer Therapy Nat. Rev. Cancer 2005, 5, 689-698
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 689-698
-
-
Kaelin, Jr.W.G.1
-
94
-
-
79959376888
-
Selective Killing of ATM- or p53-Deficient Cancer Cells through Inhibition of ATR
-
Reaper, P. M.; Griffiths, M. R.; Long, J. M.; Charrier, J.-D.; Maccormick, S.; Charlton, P. A.; Golec, J. M. C.; Pollard, J. R. Selective Killing of ATM- or p53-Deficient Cancer Cells through Inhibition of ATR Nat. Chem. Biol. 2011, 7, 428-430
-
(2011)
Nat. Chem. Biol.
, vol.7
, pp. 428-430
-
-
Reaper, P.M.1
Griffiths, M.R.2
Long, J.M.3
Charrier, J.-D.4
Maccormick, S.5
Charlton, P.A.6
Golec, J.M.C.7
Pollard, J.R.8
-
95
-
-
0035125901
-
Synthetic Lethality between Mutation in Atm and DNA-PK(cs) during Murine Embryogenesis
-
Gurley, K. E.; Kemp, C. J. Synthetic Lethality between Mutation in Atm and DNA-PK(cs) during Murine Embryogenesis Curr. Biol. 2001, 11, 191-194
-
(2001)
Curr. Biol.
, vol.11
, pp. 191-194
-
-
Gurley, K.E.1
Kemp, C.J.2
-
96
-
-
69249240178
-
The Combined Status of ATM and p53 Link Tumor Development with Therapeutic Response
-
Jiang, H.; Reinhardt, H. C.; Bartkova, J.; Tommiska, J.; Blomqvist, C.; Nevanlinna, H.; Bartek, J.; Yaffe, M. B.; Hemann, M. T. The Combined Status of ATM and p53 Link Tumor Development with Therapeutic Response Genes Dev. 2009, 23, 1895-1909
-
(2009)
Genes Dev.
, vol.23
, pp. 1895-1909
-
-
Jiang, H.1
Reinhardt, H.C.2
Bartkova, J.3
Tommiska, J.4
Blomqvist, C.5
Nevanlinna, H.6
Bartek, J.7
Yaffe, M.B.8
Hemann, M.T.9
-
97
-
-
0028217223
-
Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-Kinase
-
Powis, G.; Bonjouklian, R.; Berggren, M. M.; Gallegos, A.; Abraham, R.; Ashendel, C.; Zalkow, L.; Matter, W. F.; Dodge, J.; Grindey, G. Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-Kinase Cancer Res. 1994, 54, 2419-2423
-
(1994)
Cancer Res.
, vol.54
, pp. 2419-2423
-
-
Powis, G.1
Bonjouklian, R.2
Berggren, M.M.3
Gallegos, A.4
Abraham, R.5
Ashendel, C.6
Zalkow, L.7
Matter, W.F.8
Dodge, J.9
Grindey, G.10
-
98
-
-
0032189483
-
Inhibition of Phosphoinositide 3-Kinase Related Kinases by the Radiosensitizing Agent Wortmannin
-
Sarkaria, J. N.; Tibbetts, R. S.; Busby, E. C.; Kennedy, A. P.; Hill, D. E.; Abraham, R. T. Inhibition of Phosphoinositide 3-Kinase Related Kinases by the Radiosensitizing Agent Wortmannin Cancer Res. 1998, 58, 4375-4382
-
(1998)
Cancer Res.
, vol.58
, pp. 4375-4382
-
-
Sarkaria, J.N.1
Tibbetts, R.S.2
Busby, E.C.3
Kennedy, A.P.4
Hill, D.E.5
Abraham, R.T.6
-
99
-
-
0028170210
-
A Specific Inhibitor of Phosphatidylinositol 3-Kinase, 2-(4-Morpholinyl)-8-phenyl-4 H -1-benzopyran-4-one (3)
-
Vlahos, C. J.; Matter, W. F.; Hui, K. Y.; Brown, R. F. A Specific Inhibitor of Phosphatidylinositol 3-Kinase, 2-(4-Morpholinyl)-8-phenyl-4 H -1-benzopyran-4-one (3) J. Biol. Chem. 1994, 269, 5241-5248
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 5241-5248
-
-
Vlahos, C.J.1
Matter, W.F.2
Hui, K.Y.3
Brown, R.F.4
-
100
-
-
0026726483
-
The Inhibition of Phosphatidylinositol 3-Kinase by Quercetin and Analogs
-
Matter, W. F.; Brown, R. F.; Vlahos, C. J. The Inhibition of Phosphatidylinositol 3-Kinase by Quercetin and Analogs Biochem. Biophys. Res. Commun. 1992, 186, 624-631
-
(1992)
Biochem. Biophys. Res. Commun.
, vol.186
, pp. 624-631
-
-
Matter, W.F.1
Brown, R.F.2
Vlahos, C.J.3
-
101
-
-
0033152759
-
Competitive and Noncompetitive Inhibition of the DNA-Dependent Protein Kinase
-
Izzard, R. A.; Jackson, S. P.; Smith, G. C. Competitive and Noncompetitive Inhibition of the DNA-Dependent Protein Kinase Cancer Res. 1999, 59, 2581-2586
-
(1999)
Cancer Res.
, vol.59
, pp. 2581-2586
-
-
Izzard, R.A.1
Jackson, S.P.2
Smith, G.C.3
-
102
-
-
0029831167
-
Direct Inhibition of the Signaling Functions of the Mammalian Target of Rapamycin by the Phosphoinositide 3-Kinase Inhibitors, Wortmannin and 3
-
Brunn, G. J.; Williams, J.; Sabers, C.; Wiederrecht, G.; Lawrence, J. C., Jr.; Abraham, R. T. Direct Inhibition of the Signaling Functions of the Mammalian Target of Rapamycin by the Phosphoinositide 3-Kinase Inhibitors, Wortmannin and 3 EMBO J. 1996, 15, 5256-5267
-
(1996)
EMBO J.
, vol.15
, pp. 5256-5267
-
-
Brunn, G.J.1
Williams, J.2
Sabers, C.3
Wiederrecht, G.4
Lawrence, Jr.J.C.5
Abraham, R.T.6
-
103
-
-
34247339936
-
Exploring the Specificity of the PI3K Family Inhibitor 3
-
Gharbi, S. I.; Zvelebil, M. J.; Shuttleworth, S. J.; Hancox, T.; Saghir, N.; Timms, J. F.; Waterfield, M. D. Exploring the Specificity of the PI3K Family Inhibitor 3 Biochem. J. 2007, 404, 15-21
-
(2007)
Biochem. J.
, vol.404
, pp. 15-21
-
-
Gharbi, S.I.1
Zvelebil, M.J.2
Shuttleworth, S.J.3
Hancox, T.4
Saghir, N.5
Timms, J.F.6
Waterfield, M.D.7
-
104
-
-
84896701144
-
The Commonly Used PI3-Kinase Probe 3 Is an Inhibitor of BET Bromodomains
-
Dittmann, A.; Werner, T.; Chung, C. W.; Savitski, M. M.; Fälth Savitski, M.; Grandi, P.; Hopf, C.; Lindon, M.; Neubauer, G.; Prinjha, R. K.; Bantscheff, M.; Drewes, G. The Commonly Used PI3-Kinase Probe 3 Is an Inhibitor of BET Bromodomains ACS Chem. Biol. 2014, 9, 495-502
-
(2014)
ACS Chem. Biol.
, vol.9
, pp. 495-502
-
-
Dittmann, A.1
Werner, T.2
Chung, C.W.3
Savitski, M.M.4
Fälth Savitski, M.5
Grandi, P.6
Hopf, C.7
Lindon, M.8
Neubauer, G.9
Prinjha, R.K.10
Bantscheff, M.11
Drewes, G.12
-
105
-
-
0034100051
-
In Vivo and in Vitro Ovarian Carcinoma Growth Inhibition by a Phosphatidylinositol 3-Kinase Inhibitor (3)
-
Hu, L.; Zaloudek, C.; Mills, G. B.; Gray, J.; Jaffe, R. B. In Vivo and in Vitro Ovarian Carcinoma Growth Inhibition by a Phosphatidylinositol 3-Kinase Inhibitor (3) Clin. Cancer Res. 2000, 6, 880-886
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 880-886
-
-
Hu, L.1
Zaloudek, C.2
Mills, G.B.3
Gray, J.4
Jaffe, R.B.5
-
106
-
-
0032488972
-
G1 Phase Arrest by the Phosphatidylinositol 3-Kinase Inhibitor LY 294002 Is Correlated to Up-Regulation of p27Kip1 and Inhibition of G1 CDKs in Choroidal Melanoma Cells
-
Casagrande, F.; Bacqueville, D.; Pillaire, M. J.; Malecaze, F.; Manenti, S.; Breton-Douillon, M.; Darbon, J. M. G1 Phase Arrest by the Phosphatidylinositol 3-Kinase Inhibitor LY 294002 Is Correlated to Up-Regulation of p27Kip1 and Inhibition of G1 CDKs in Choroidal Melanoma Cells FEBS Lett. 1998, 422, 385-390
-
(1998)
FEBS Lett.
, vol.422
, pp. 385-390
-
-
Casagrande, F.1
Bacqueville, D.2
Pillaire, M.J.3
Malecaze, F.4
Manenti, S.5
Breton-Douillon, M.6
Darbon, J.M.7
-
107
-
-
0034652392
-
Phosphatidylinositol 3-Kinase Signaling Mediates Angiogenesis and Expression of Vascular Endothelial Growth Factor in Endothelial Cells
-
Jiang, B. H.; Zheng, J. Z.; Aoki, M.; Vogt, P. K. Phosphatidylinositol 3-Kinase Signaling Mediates Angiogenesis and Expression of Vascular Endothelial Growth Factor in Endothelial Cells Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1749-1753
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 1749-1753
-
-
Jiang, B.H.1
Zheng, J.Z.2
Aoki, M.3
Vogt, P.K.4
-
108
-
-
39149123820
-
A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity
-
Garlich, J. R.; De, P.; Dey, N.; Su, J. D.; Peng, X.; Miller, A.; Murali, R.; Lu, Y.; Mills, G. B.; Kundra, V.; Shu, H.-K.; Peng, Q.; Durden, D. L. A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity Cancer Res. 2008, 68, 206-215
-
(2008)
Cancer Res.
, vol.68
, pp. 206-215
-
-
Garlich, J.R.1
De, P.2
Dey, N.3
Su, J.D.4
Peng, X.5
Miller, A.6
Murali, R.7
Lu, Y.8
Mills, G.B.9
Kundra, V.10
Shu, H.-K.11
Peng, Q.12
Durden, D.L.13
-
109
-
-
84869505566
-
Phase i Pharmacokinetic and Pharmacodynamic Study of the Pan-PI3K/mTORC Vascular Targeted pro-Drug SF1126 in Patients with Advanced Solid Tumours and B-Cell Malignancies
-
Mahadevan, D.; Chiorean, E. G.; Harris, W. B.; Von Hoff, D. D.; Stejskal-Barnett, A.; Qi, W.; Anthony, S. P.; Younger, A. E.; Rensvold, D. M.; Cordova, F.; Shelton, C. F.; Becker, M. D.; Garlich, J. R.; Durden, D. L.; Ramanathan, R. K. Phase I Pharmacokinetic and Pharmacodynamic Study of the Pan-PI3K/mTORC Vascular Targeted pro-Drug SF1126 in Patients with Advanced Solid Tumours and B-Cell Malignancies Eur. J. Cancer 2012, 48, 3319-3327
-
(2012)
Eur. J. Cancer
, vol.48
, pp. 3319-3327
-
-
Mahadevan, D.1
Chiorean, E.G.2
Harris, W.B.3
Von Hoff, D.D.4
Stejskal-Barnett, A.5
Qi, W.6
Anthony, S.P.7
Younger, A.E.8
Rensvold, D.M.9
Cordova, F.10
Shelton, C.F.11
Becker, M.D.12
Garlich, J.R.13
Durden, D.L.14
Ramanathan, R.K.15
-
110
-
-
0033634827
-
Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, 3, Quercetin, Myricetin, and Staurosporine
-
Walker, E. H.; Pacold, M. E.; Perisic, O.; Stephens, L.; Hawkins, P. T.; Wymann, M. P.; Williams, R. L. Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, 3, Quercetin, Myricetin, and Staurosporine Mol. Cell 2000, 6, 909-919
-
(2000)
Mol. Cell
, vol.6
, pp. 909-919
-
-
Walker, E.H.1
Pacold, M.E.2
Perisic, O.3
Stephens, L.4
Hawkins, P.T.5
Wymann, M.P.6
Williams, R.L.7
-
111
-
-
35348919126
-
-
WO2004016607.
-
Jackson, S.; Robertson, A. D.; Kenche, V.; Thompson, P.; Prabaharan, H.; Anderson, K.; Abbott, B.; Goncalves, I.; Nesbitt, W.; Schoenwaelder, S.; Saylik, D. Inhibition of Phosphoinositide 3-Kinase Beta. WO2004016607, 2004.
-
(2004)
Inhibition of Phosphoinositide 3-Kinase Beta
-
-
Jackson, S.1
Robertson, A.D.2
Kenche, V.3
Thompson, P.4
Prabaharan, H.5
Anderson, K.6
Abbott, B.7
Goncalves, I.8
Nesbitt, W.9
Schoenwaelder, S.10
Saylik, D.11
-
112
-
-
80755125565
-
Comprehensive Assay of Kinase Catalytic Activity Reveals Features of Kinase Inhibitor Selectivity
-
Anastassiadis, T.; Deacon, S. W.; Devarajan, K.; Ma, H.; Peterson, M. R. Comprehensive Assay of Kinase Catalytic Activity Reveals Features of Kinase Inhibitor Selectivity Nat. Biotechnol. 2011, 11, 1039-1045
-
(2011)
Nat. Biotechnol.
, vol.11
, pp. 1039-1045
-
-
Anastassiadis, T.1
Deacon, S.W.2
Devarajan, K.3
Ma, H.4
Peterson, M.R.5
-
113
-
-
80755125575
-
Comprehensive Analysis of Kinase Inhibitor Selectivity
-
Davis, M. I.; Hunt, J. P.; Herrgard, S.; Ciceri, P.; Wodicka, L. M.; Pallares, G.; Hocker, M.; Treiber, D. K.; Zarrinkar, P. P. Comprehensive Analysis of Kinase Inhibitor Selectivity Nat. Biotechnol. 2011, 11, 1046-1051
-
(2011)
Nat. Biotechnol.
, vol.11
, pp. 1046-1051
-
-
Davis, M.I.1
Hunt, J.P.2
Herrgard, S.3
Ciceri, P.4
Wodicka, L.M.5
Pallares, G.6
Hocker, M.7
Treiber, D.K.8
Zarrinkar, P.P.9
-
115
-
-
0042521121
-
2,6-Disubstituted Pyran-4-one and Thiopyran-4-one Inhibitors of DNA-Dependent Protein Kinase (DNA-PK)
-
Hollick, J. J.; Golding, B. T.; Hardcastle, I. R.; Martin, N.; Richardson, C.; Rigoreau, L. J. M.; Smith, G. C. M.; Griffin, R. J. 2,6-Disubstituted Pyran-4-one and Thiopyran-4-one Inhibitors of DNA-Dependent Protein Kinase (DNA-PK) Bioorg. Med. Chem. Lett. 2003, 13, 3083-3086
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 3083-3086
-
-
Hollick, J.J.1
Golding, B.T.2
Hardcastle, I.R.3
Martin, N.4
Richardson, C.5
Rigoreau, L.J.M.6
Smith, G.C.M.7
Griffin, R.J.8
-
116
-
-
19944432425
-
Selective Benzopyranone and Pyrimido[2,1-A]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure-Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro
-
Griffin, R. J.; Fontana, G.; Golding, B. T.; Guiard, S.; Hardcastle, I. R.; Leahy, J. J. J.; Martin, N.; Richardson, C.; Rigoreau, L.; Stockley, M.; Smith, G. C. M. Selective Benzopyranone and Pyrimido[2,1-a]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure-Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro J. Med. Chem. 2005, 48, 569-585
-
(2005)
J. Med. Chem.
, vol.48
, pp. 569-585
-
-
Griffin, R.J.1
Fontana, G.2
Golding, B.T.3
Guiard, S.4
Hardcastle, I.R.5
Leahy, J.J.J.6
Martin, N.7
Richardson, C.8
Rigoreau, L.9
Stockley, M.10
Smith, G.C.M.11
-
117
-
-
28144463966
-
Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach
-
Hardcastle, I. R.; Cockcroft, X.; Curtin, N. J.; El-Murr, M. D.; Leahy, J. J. J.; Stockley, M.; Golding, B. T.; Rigoreau, L.; Richardson, C.; Smith, G. C. M.; Griffin, R. J. Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach J. Med. Chem. 2005, 48, 7829-7846
-
(2005)
J. Med. Chem.
, vol.48
, pp. 7829-7846
-
-
Hardcastle, I.R.1
Cockcroft, X.2
Curtin, N.J.3
El-Murr, M.D.4
Leahy, J.J.J.5
Stockley, M.6
Golding, B.T.7
Rigoreau, L.8
Richardson, C.9
Smith, G.C.M.10
Griffin, R.J.11
-
118
-
-
84861802948
-
Mitoxantrone in Combination with a DNA-PK Inhibitor: Possible Therapy of Promyelocytic Leukaemia Resistant Forms
-
Mikusová, V.; Tichy, A.; Rezácová, M.; Vávrová, J. Mitoxantrone in Combination with a DNA-PK Inhibitor: Possible Therapy of Promyelocytic Leukaemia Resistant Forms Folia Biol. (Praha) 2011, 57, 200-205
-
(2011)
Folia Biol. (Praha)
, vol.57
, pp. 200-205
-
-
Mikusová, V.1
Tichy, A.2
Rezácová, M.3
Vávrová, J.4
-
119
-
-
34248594725
-
Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase
-
Amrein, L.; Loignon, M.; Goulet, A.-C.; Dunn, M.; Jean-Claude, B.; Aloyz, R.; Panasci, L. Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase J. Pharmacol. Exp. Ther. 2007, 321, 848-855
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.321
, pp. 848-855
-
-
Amrein, L.1
Loignon, M.2
Goulet, A.-C.3
Dunn, M.4
Jean-Claude, B.5
Aloyz, R.6
Panasci, L.7
-
120
-
-
84864328191
-
Irinotecan and DNA-PKcs Inhibitors Synergize in Killing of Colon Cancer Cells
-
Davidson, D.; Coulombe, Y.; Martinez-Marignac, V. L.; Amrein, L.; Grenier, J.; Hodkinson, K.; Masson, J.-Y.; Aloyz, R.; Panasci, L. Irinotecan and DNA-PKcs Inhibitors Synergize in Killing of Colon Cancer Cells Invest. New Drugs 2012, 30, 1248-1256
-
(2012)
Invest. New Drugs
, vol.30
, pp. 1248-1256
-
-
Davidson, D.1
Coulombe, Y.2
Martinez-Marignac, V.L.3
Amrein, L.4
Grenier, J.5
Hodkinson, K.6
Masson, J.-Y.7
Aloyz, R.8
Panasci, L.9
-
121
-
-
2942591949
-
A Novel DNA-Dependent Protein Kinase Inhibitor, NU7026, Potentiates the Cytotoxicity of Topoisomerase II Poisons Used in the Treatment of Leukemia
-
Willmore, E.; de Caux, S.; Sunter, N. J.; Tilby, M. J.; Jackson, G. H.; Austin, C. A.; Durkacz, B. W. A Novel DNA-Dependent Protein Kinase Inhibitor, NU7026, Potentiates the Cytotoxicity of Topoisomerase II Poisons Used in the Treatment of Leukemia Blood 2004, 103, 4659-4665
-
(2004)
Blood
, vol.103
, pp. 4659-4665
-
-
Willmore, E.1
De Caux, S.2
Sunter, N.J.3
Tilby, M.J.4
Jackson, G.H.5
Austin, C.A.6
Durkacz, B.W.7
-
122
-
-
27644509749
-
Preclinical Pharmacokinetics and Metabolism of a Novel Prototype DNA-PK Inhibitor NU7026
-
Nutley, B. P.; Smith, N. F.; Hayes, A.; Kelland, L. R.; Brunton, L.; Golding, B. T.; Smith, G. C. M.; Martin, N. M. B.; Workman, P.; Raynaud, F. I. Preclinical Pharmacokinetics and Metabolism of a Novel Prototype DNA-PK Inhibitor NU7026 Br. J. Cancer 2005, 93, 1011-1018
-
(2005)
Br. J. Cancer
, vol.93
, pp. 1011-1018
-
-
Nutley, B.P.1
Smith, N.F.2
Hayes, A.3
Kelland, L.R.4
Brunton, L.5
Golding, B.T.6
Smith, G.C.M.7
Martin, N.M.B.8
Workman, P.9
Raynaud, F.I.10
-
123
-
-
34247265530
-
Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure-Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase
-
Hollick, J. J.; Rigoreau, L. J. M.; Cano-Soumillac, C.; Cockcroft, X.; Curtin, N. J.; Frigerio, M.; Golding, B. T.; Guiard, S.; Hardcastle, I. R.; Hickson, I.; Hummersone, M. G.; Menear, K. A.; Martin, N. M. B.; Matthews, I.; Newell, D. R.; Ord, R.; Richardson, C. J.; Smith, G. C. M.; Griffin, R. J. Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure-Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase J. Med. Chem. 2007, 50, 1958-1972
-
(2007)
J. Med. Chem.
, vol.50
, pp. 1958-1972
-
-
Hollick, J.J.1
Rigoreau, L.J.M.2
Cano-Soumillac, C.3
Cockcroft, X.4
Curtin, N.J.5
Frigerio, M.6
Golding, B.T.7
Guiard, S.8
Hardcastle, I.R.9
Hickson, I.10
Hummersone, M.G.11
Menear, K.A.12
Martin, N.M.B.13
Matthews, I.14
Newell, D.R.15
Ord, R.16
Richardson, C.J.17
Smith, G.C.M.18
Griffin, R.J.19
-
124
-
-
9744271049
-
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
-
Hickson, I.; Yan, Z.; Richardson, C. J.; Green, S. J.; Martin, N. M. B.; Orr, A. I.; Reaper, P. M.; Jackson, S. P.; Curtin, N. J.; Smith, G. C. M. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM Cancer Res. 2004, 64, 9152-9159
-
(2004)
Cancer Res.
, vol.64
, pp. 9152-9159
-
-
Hickson, I.1
Yan, Z.2
Richardson, C.J.3
Green, S.J.4
Martin, N.M.B.5
Orr, A.I.6
Reaper, P.M.7
Jackson, S.P.8
Curtin, N.J.9
Smith, G.C.M.10
-
125
-
-
0032508504
-
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
-
Banin, S.; Moyal, L.; Shieh, S.; Taya, Y.; Anderson, C. W.; Chessa, L.; Smorodinsky, N. I.; Prives, C.; Reiss, Y.; Shiloh, Y.; Ziv, Y. Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage Science 1998, 281, 1674-1677
-
(1998)
Science
, vol.281
, pp. 1674-1677
-
-
Banin, S.1
Moyal, L.2
Shieh, S.3
Taya, Y.4
Anderson, C.W.5
Chessa, L.6
Smorodinsky, N.I.7
Prives, C.8
Reiss, Y.9
Shiloh, Y.10
Ziv, Y.11
-
126
-
-
8844254050
-
Identification of a Highly Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor (NU7441) by Screening of Chromenone Libraries
-
Leahy, J. J. J.; Golding, B. T.; Griffin, R. J.; Hardcastle, I. R.; Richardson, C.; Rigoreau, L.; Smith, G. C. M. Identification of a Highly Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor (NU7441) by Screening of Chromenone Libraries Bioorg. Med. Chem. Lett. 2004, 14, 6083-6087
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 6083-6087
-
-
Leahy, J.J.J.1
Golding, B.T.2
Griffin, R.J.3
Hardcastle, I.R.4
Richardson, C.5
Rigoreau, L.6
Smith, G.C.M.7
-
127
-
-
28244461575
-
Sensitization of Breast Carcinoma Cells to Ionizing Radiation by Small Molecule Inhibitors of DNA-Dependent Protein Kinase and Ataxia Telangiectsia Mutated
-
Cowell, I. G.; Durkacz, B. W.; Tilby, M. J. Sensitization of Breast Carcinoma Cells to Ionizing Radiation by Small Molecule Inhibitors of DNA-Dependent Protein Kinase and Ataxia Telangiectsia Mutated Biochem. Pharmacol. 2005, 71, 13-20
-
(2005)
Biochem. Pharmacol.
, vol.71
, pp. 13-20
-
-
Cowell, I.G.1
Durkacz, B.W.2
Tilby, M.J.3
-
128
-
-
84895921800
-
Radio-Sensitization of Human Leukaemic MOLT-4 Cells by DNA-Dependent Protein Kinase Inhibitor, NU7441
-
Tichy, A.; Durisova, K.; Salovska, B.; Pejchal, J.; Zarybnicka, L.; Vavrova, J.; Dye, N. A.; Sinkorova, Z. Radio-Sensitization of Human Leukaemic MOLT-4 Cells by DNA-Dependent Protein Kinase Inhibitor, NU7441 Radiat. Environ. Biophys. 2014, 53, 83-92
-
(2014)
Radiat. Environ. Biophys.
, vol.53
, pp. 83-92
-
-
Tichy, A.1
Durisova, K.2
Salovska, B.3
Pejchal, J.4
Zarybnicka, L.5
Vavrova, J.6
Dye, N.A.7
Sinkorova, Z.8
-
129
-
-
84856700210
-
Further Characterisation of the Cellular Activity of the DNA-PK Inhibitor, NU7441, Reveals Potential Cross-Talk with Homologous Recombination
-
Tavecchio, M.; Munck, J. M.; Cano, C.; Newell, D. R.; Curtin, N. J. Further Characterisation of the Cellular Activity of the DNA-PK Inhibitor, NU7441, Reveals Potential Cross-Talk with Homologous Recombination Cancer Chemother. Pharmacol. 2012, 69, 155-164
-
(2012)
Cancer Chemother. Pharmacol.
, vol.69
, pp. 155-164
-
-
Tavecchio, M.1
Munck, J.M.2
Cano, C.3
Newell, D.R.4
Curtin, N.J.5
-
130
-
-
33744924482
-
Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441
-
Zhao, Y.; Thomas, H. D.; Batey, M. A.; Cowell, I. G.; Richardson, C. J.; Griffin, R. J.; Calvert, A. H.; Newell, D. R.; Smith, G. C. M.; Curtin, N. J. Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441 Cancer Res. 2006, 66, 5354-5362
-
(2006)
Cancer Res.
, vol.66
, pp. 5354-5362
-
-
Zhao, Y.1
Thomas, H.D.2
Batey, M.A.3
Cowell, I.G.4
Richardson, C.J.5
Griffin, R.J.6
Calvert, A.H.7
Newell, D.R.8
Smith, G.C.M.9
Curtin, N.J.10
-
131
-
-
34547561318
-
Quinolinone and Pyridopyrimidinone Inhibitors of DNA-Dependent Protein Kinase
-
Barbeau, O. R.; Cano-Soumillac, C.; Griffin, R. J.; Hardcastle, I. R.; Smith, G. C. M.; Richardson, C.; Clegg, W.; Harrington, R. W.; Golding, B. T. Quinolinone and Pyridopyrimidinone Inhibitors of DNA-Dependent Protein Kinase Org. Biomol. Chem. 2007, 5, 2670-2677
-
(2007)
Org. Biomol. Chem.
, vol.5
, pp. 2670-2677
-
-
Barbeau, O.R.1
Cano-Soumillac, C.2
Griffin, R.J.3
Hardcastle, I.R.4
Smith, G.C.M.5
Richardson, C.6
Clegg, W.7
Harrington, R.W.8
Golding, B.T.9
-
132
-
-
49849088557
-
8-Biarylchromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK)
-
Desage-El Murr, M.; Cano, C.; Golding, B. T.; Hardcastle, I. R.; Hummersome, M.; Frigerio, M.; Curtin, N. J.; Menear, K.; Richardson, C.; Smith, G. C. M.; Griffin, R. J. 8-Biarylchromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Bioorg. Med. Chem. Lett. 2008, 18, 4885-4890
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4885-4890
-
-
Desage-El Murr, M.1
Cano, C.2
Golding, B.T.3
Hardcastle, I.R.4
Hummersome, M.5
Frigerio, M.6
Curtin, N.J.7
Menear, K.8
Richardson, C.9
Smith, G.C.M.10
Griffin, R.J.11
-
133
-
-
84883203492
-
1-Substituted (Dibenzo[ b, d ]thiophen-4-yl)-2-morpholino-4 H -chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity
-
Cano, C.; Saravanan, K.; Bailey, C.; Bardos, J.; Curtin, N. J.; Frigerio, M.; Golding, B. T.; Hardcastle, I. R.; Hummersone, M. G.; Menear, K. A.; Newell, D. R.; Richardson, C. J.; Shea, K.; Smith, G. C. M.; Thommes, P.; Ting, A.; Griffin, R. J. 1-Substituted (Dibenzo[ b, d ]thiophen-4-yl)-2-morpholino-4 H -chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity J. Med. Chem. 2013, 56, 6386-6401
-
(2013)
J. Med. Chem.
, vol.56
, pp. 6386-6401
-
-
Cano, C.1
Saravanan, K.2
Bailey, C.3
Bardos, J.4
Curtin, N.J.5
Frigerio, M.6
Golding, B.T.7
Hardcastle, I.R.8
Hummersone, M.G.9
Menear, K.A.10
Newell, D.R.11
Richardson, C.J.12
Shea, K.13
Smith, G.C.M.14
Thommes, P.15
Ting, A.16
Griffin, R.J.17
-
134
-
-
78751644441
-
DNA-Dependent Protein Kinase (DNA-PK) Inhibitors: Structure-Activity Relationships for O -Alkoxyphenylchromen-4-one Probes of the ATP-Binding Domain
-
Clapham, K. M.; Bardos, J.; Finlay, M. R. V.; Golding, B. T.; Griffen, E. J.; Griffin, R. J.; Hardcastle, I. R.; Menear, K. A.; Ting, A.; Turner, P.; Young, G. L.; Cano, C. DNA-Dependent Protein Kinase (DNA-PK) Inhibitors: Structure-Activity Relationships for O -Alkoxyphenylchromen-4-one Probes of the ATP-Binding Domain Bioorg. Med. Chem. Lett. 2011, 21, 966-970
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 966-970
-
-
Clapham, K.M.1
Bardos, J.2
Finlay, M.R.V.3
Golding, B.T.4
Griffen, E.J.5
Griffin, R.J.6
Hardcastle, I.R.7
Menear, K.A.8
Ting, A.9
Turner, P.10
Young, G.L.11
Cano, C.12
-
135
-
-
78650350366
-
DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-Oone Surrogates for the Chromen-4-one Chemotype
-
Cano, C.; Barbeau, O. R.; Bailey, C.; Cockcroft, X.-L.; Curtin, N. J.; Duggan, H.; Frigerio, M.; Golding, B. T.; Hardcastle, I. R.; Hummersone, M. G.; Knights, C.; Menear, K. A.; Newell, D. R.; Richardson, C. J.; Smith, G. C. M.; Spittle, B.; Griffin, R. J. DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-Oone Surrogates for the Chromen-4-one Chemotype J. Med. Chem. 2010, 53, 8498-8507
-
(2010)
J. Med. Chem.
, vol.53
, pp. 8498-8507
-
-
Cano, C.1
Barbeau, O.R.2
Bailey, C.3
Cockcroft, X.-L.4
Curtin, N.J.5
Duggan, H.6
Frigerio, M.7
Golding, B.T.8
Hardcastle, I.R.9
Hummersone, M.G.10
Knights, C.11
Menear, K.A.12
Newell, D.R.13
Richardson, C.J.14
Smith, G.C.M.15
Spittle, B.16
Griffin, R.J.17
-
136
-
-
84864875154
-
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
-
Munck, J. M.; Batey, M. A.; Zhao, Y.; Jenkins, H.; Richardson, C. J.; Cano, C.; Tavecchio, M.; Barbeau, J.; Bardos, J.; Cornell, L.; Griffin, R. J.; Menear, K.; Slade, A.; Thommes, P.; Martin, N. M. B.; Newell, D. R.; Smith, G. C. M.; Curtin, N. J. Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K Mol. Cancer Ther. 2012, 11, 1789-1798
-
(2012)
Mol. Cancer Ther.
, vol.11
, pp. 1789-1798
-
-
Munck, J.M.1
Batey, M.A.2
Zhao, Y.3
Jenkins, H.4
Richardson, C.J.5
Cano, C.6
Tavecchio, M.7
Barbeau, J.8
Bardos, J.9
Cornell, L.10
Griffin, R.J.11
Menear, K.12
Slade, A.13
Thommes, P.14
Martin, N.M.B.15
Newell, D.R.16
Smith, G.C.M.17
Curtin, N.J.18
-
137
-
-
70350238489
-
Improved ATM Kinase Inhibitor KU-60019 Radiosensitizes Glioma Cells, Compromises Insulin, AKT and ERK Prosurvival Signaling, and Inhibits Migration and Invasion
-
Golding, S. E.; Rosenberg, E.; Valerie, N.; Hussaini, I.; Frigerio, M.; Cockcroft, X. F.; Chong, W. Y.; Hummersone, M.; Rigoreau, L.; Menear, K. A.; OConnor, M. J.; Povirk, L. F.; van Meter, T.; Valerie, K. Improved ATM Kinase Inhibitor KU-60019 Radiosensitizes Glioma Cells, Compromises Insulin, AKT and ERK Prosurvival Signaling, and Inhibits Migration and Invasion Mol. Cancer Ther. 2009, 8, 2894-2902
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 2894-2902
-
-
Golding, S.E.1
Rosenberg, E.2
Valerie, N.3
Hussaini, I.4
Frigerio, M.5
Cockcroft, X.F.6
Chong, W.Y.7
Hummersone, M.8
Rigoreau, L.9
Menear, K.A.10
Oconnor, M.J.11
Povirk, L.F.12
Van Meter, T.13
Valerie, K.14
-
138
-
-
84858722796
-
Dynamic Inhibition of ATM Kinase Provides a Strategy for Glioblastoma Multiforme Radiosensitization and Growth Control
-
Golding, S. E.; Rosenberg, E.; Adams, B. R.; Wignarajah, S.; Beckta, J. M.; OConnor, M. J.; Valerie, K. Dynamic Inhibition of ATM Kinase Provides a Strategy for Glioblastoma Multiforme Radiosensitization and Growth Control Cell Cycle 2012, 11, 1167-1173
-
(2012)
Cell Cycle
, vol.11
, pp. 1167-1173
-
-
Golding, S.E.1
Rosenberg, E.2
Adams, B.R.3
Wignarajah, S.4
Beckta, J.M.5
Oconnor, M.J.6
Valerie, K.7
-
139
-
-
84900000610
-
Predictability, Efficacy and Safety of Radiosensitization of Glioblastoma-Initiating Cells by the ATM Inhibitor KU-60019
-
Vecchio, D.; Daga, A.; Carra, E.; Marubbi, D.; Baio, G.; Neumaier, C. E.; Vagge, S.; Corvo, R.; Pia Brisigotti, M.; Louis Ravetti, J.; Zunino, A.; Poggi, A.; Mascelli, S.; Raso, A.; Frosina, G. Predictability, Efficacy and Safety of Radiosensitization of Glioblastoma-Initiating Cells by the ATM Inhibitor KU-60019 Int. J. Cancer 2013, 135, 479-491
-
(2013)
Int. J. Cancer
, vol.135
, pp. 479-491
-
-
Vecchio, D.1
Daga, A.2
Carra, E.3
Marubbi, D.4
Baio, G.5
Neumaier, C.E.6
Vagge, S.7
Corvo, R.8
Pia Brisigotti, M.9
Louis Ravetti, J.10
Zunino, A.11
Poggi, A.12
Mascelli, S.13
Raso, A.14
Frosina, G.15
-
140
-
-
77950336368
-
Atropisomeric 8-Arylchromen-4-ones Exhibit Enantioselective Inhibition of the DNA-Dependent Protein Kinase (DNA-PK)
-
Cano, C.; Golding, B. T.; Haggerty, K.; Hardcastle, I. R.; Peacock, M.; Griffin, R. J. Atropisomeric 8-Arylchromen-4-ones Exhibit Enantioselective Inhibition of the DNA-Dependent Protein Kinase (DNA-PK) Org. Biomol. Chem. 2010, 8, 1922-1928
-
(2010)
Org. Biomol. Chem.
, vol.8
, pp. 1922-1928
-
-
Cano, C.1
Golding, B.T.2
Haggerty, K.3
Hardcastle, I.R.4
Peacock, M.5
Griffin, R.J.6
-
141
-
-
84864633030
-
Potent Enantioselective Inhibition of DNA-Dependent Protein Kinase (DNA-PK) by Atropisomeric Chromenone Derivatives
-
Clapham, K. M.; Rennison, T.; Jones, G.; Craven, F.; Bardos, J.; Golding, B. T.; Griffin, R. J.; Haggerty, K.; Hardcastle, I. R.; Thommes, P.; Ting, A.; Cano, C. Potent Enantioselective Inhibition of DNA-Dependent Protein Kinase (DNA-PK) by Atropisomeric Chromenone Derivatives Org. Biomol. Chem. 2012, 10, 6747-6757
-
(2012)
Org. Biomol. Chem.
, vol.10
, pp. 6747-6757
-
-
Clapham, K.M.1
Rennison, T.2
Jones, G.3
Craven, F.4
Bardos, J.5
Golding, B.T.6
Griffin, R.J.7
Haggerty, K.8
Hardcastle, I.R.9
Thommes, P.10
Ting, A.11
Cano, C.12
-
142
-
-
77954213488
-
Mapping the ATP-Binding Domain of DNA-Dependent Protein Kinase (DNA-PK) with Coumarin- and Isocoumarin-Derived Inhibitors
-
Payne, S. L.; Rodriguez-Aristegui, S.; Bardos, J.; Cano, C.; Golding, B. T.; Hardcastle, I. R.; Peacock, M.; Parveen, N.; Griffin, R. J. Mapping the ATP-Binding Domain of DNA-Dependent Protein Kinase (DNA-PK) with Coumarin- and Isocoumarin-Derived Inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 3649-3653
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 3649-3653
-
-
Payne, S.L.1
Rodriguez-Aristegui, S.2
Bardos, J.3
Cano, C.4
Golding, B.T.5
Hardcastle, I.R.6
Peacock, M.7
Parveen, N.8
Griffin, R.J.9
-
143
-
-
34547731461
-
Synthesis, Identification and Antiplatelet Evaluation of 2-Morpholino Substituted Benzoxazines
-
Pritchard, K. M.; Al-Rawi, J.; Bradley, C. Synthesis, Identification and Antiplatelet Evaluation of 2-Morpholino Substituted Benzoxazines Eur. J. Med. Chem. 2007, 42, 1200-1210
-
(2007)
Eur. J. Med. Chem.
, vol.42
, pp. 1200-1210
-
-
Pritchard, K.M.1
Al-Rawi, J.2
Bradley, C.3
-
144
-
-
77957832718
-
Synthesis, Structural Elucidation and DNA-Dependant Protein Kinase and Antiplatelet Studies of 2-Amino-[5,6,7,8-mono and 7,8-di-substituted]-1,3-benzoxazines
-
Ihmaid, S.; Al-Rawi, J.; Bradley, C. Synthesis, Structural Elucidation and DNA-Dependant Protein Kinase and Antiplatelet Studies of 2-Amino-[5,6,7,8-mono and 7,8-di-substituted]-1,3-benzoxazines Eur. J. Med. Chem. 2010, 45, 4934-4946
-
(2010)
Eur. J. Med. Chem.
, vol.45
, pp. 4934-4946
-
-
Ihmaid, S.1
Al-Rawi, J.2
Bradley, C.3
-
145
-
-
84867043713
-
Synthesis, DNA-PK Inhibition, Anti-Platelet Activity Studies of 2-(N-Substituted-3-Aminopyridine)-Substituted-1,3-Benzoxazines and DNA-PK and PI3K Inhibition, Homology Modelling Studies of 2-Morpholino-(7,8-Di and 8-Substituted)-1,3-Benzoxazines
-
Ihmaid, S. K.; Al-Rawi, J. M. A.; Bradley, C. J.; Angove, M. J.; Robertson, M. N. Synthesis, DNA-PK Inhibition, Anti-Platelet Activity Studies of 2-(N-Substituted-3-Aminopyridine)-Substituted-1,3-Benzoxazines and DNA-PK and PI3K Inhibition, Homology Modelling Studies of 2-Morpholino-(7,8-Di and 8-Substituted)-1,3-Benzoxazines Eur. J. Med. Chem. 2012, 57, 85-101
-
(2012)
Eur. J. Med. Chem.
, vol.57
, pp. 85-101
-
-
Ihmaid, S.K.1
Al-Rawi, J.M.A.2
Bradley, C.J.3
Angove, M.J.4
Robertson, M.N.5
-
146
-
-
79959511901
-
Synthesis, Structural Elucidation, DNA-PK Inhibition, Homology Modelling and Anti-Platelet Activity of Morpholino-Substituted-1,3-Naphth-oxazines
-
Ihmaid, S.; Al-Rawi, J.; Bradley, C.; Angove, M. J.; Robertson, M. N.; Clark, R. L. Synthesis, Structural Elucidation, DNA-PK Inhibition, Homology Modelling and Anti-Platelet Activity of Morpholino-Substituted-1,3-Naphth-oxazines Bioorg. Med. Chem. 2011, 19, 3983-3994
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 3983-3994
-
-
Ihmaid, S.1
Al-Rawi, J.2
Bradley, C.3
Angove, M.J.4
Robertson, M.N.5
Clark, R.L.6
-
147
-
-
0141974936
-
Vanillins-A Novel Family of DNA-PK Inhibitors
-
Durant, S.; Karran, P. Vanillins-A Novel Family of DNA-PK Inhibitors Nucleic Acids Res. 2003, 31, 5501-5512
-
(2003)
Nucleic Acids Res.
, vol.31
, pp. 5501-5512
-
-
Durant, S.1
Karran, P.2
-
148
-
-
3843135141
-
Isoform-Specific Phosphoinositide 3-Kinase Inhibitors from an Arylmorpholine Scaffold
-
Knight, Z. A.; Chiang, G. G.; Alaimo, P. J.; Kenski, D. M.; Ho, C. B.; Coan, K.; Abraham, R. T.; Shokat, K. M. Isoform-Specific Phosphoinositide 3-Kinase Inhibitors from an Arylmorpholine Scaffold Bioorg. Med. Chem. 2004, 12, 4749-4759
-
(2004)
Bioorg. Med. Chem.
, vol.12
, pp. 4749-4759
-
-
Knight, Z.A.1
Chiang, G.G.2
Alaimo, P.J.3
Kenski, D.M.4
Ho, C.B.5
Coan, K.6
Abraham, R.T.7
Shokat, K.M.8
-
149
-
-
77954903710
-
Activity of Any Class IA PI3K Isoform Can Sustain Cell Proliferation and Survival
-
Foukas, L. C.; Berenjeno, I. M.; Gray, A.; Khwaja, A.; Vanhaesebroeck, B. Activity of Any Class IA PI3K Isoform Can Sustain Cell Proliferation and Survival Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 11381-11386
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 11381-11386
-
-
Foukas, L.C.1
Berenjeno, I.M.2
Gray, A.3
Khwaja, A.4
Vanhaesebroeck, B.5
-
150
-
-
84870680416
-
Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Cancer Treatment
-
Brana, I.; Siu, L. L. Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Cancer Treatment BMC Med. 2012, 10, 161
-
(2012)
BMC Med.
, vol.10
, pp. 161
-
-
Brana, I.1
Siu, L.L.2
-
151
-
-
84896689612
-
PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia
-
Chang, J. E.; Kahl, B. S. PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia Curr. Hematol. Malig. Rep. 2014, 9, 33-43
-
(2014)
Curr. Hematol. Malig. Rep.
, vol.9
, pp. 33-43
-
-
Chang, J.E.1
Kahl, B.S.2
-
152
-
-
84874652531
-
Novel Approaches to Inhibitor Design for the p110 Phosphoinositide 3-kinase
-
Dbouk, H. A.; Backer, J. M. Novel Approaches to Inhibitor Design for the p110 Phosphoinositide 3-kinase Trends Pharmacol. Sci. 2013, 34, 149-153
-
(2013)
Trends Pharmacol. Sci.
, vol.34
, pp. 149-153
-
-
Dbouk, H.A.1
Backer, J.M.2
-
153
-
-
84867795025
-
PI3K and PI3K as Targets for Autoimmune and Inflammatory Diseases
-
Cushing, T. D.; Metz, D. P.; Whittington, D. A.; McGee, L. R. PI3K and PI3K as Targets for Autoimmune and Inflammatory Diseases J. Med. Chem. 2012, 55, 8559-8581
-
(2012)
J. Med. Chem.
, vol.55
, pp. 8559-8581
-
-
Cushing, T.D.1
Metz, D.P.2
Whittington, D.A.3
McGee, L.R.4
-
154
-
-
0041994136
-
-
WO2001053266A1.
-
Roberson, A.; Jackson, S.; Kenche, V.; Yaip, C.; Parbaharan, H.; Thompson, P. Therapeutic Morpholino-Substituted Compounds. WO2001053266A1, 2001.
-
(2001)
Therapeutic Morpholino-Substituted Compounds
-
-
Roberson, A.1
Jackson, S.2
Kenche, V.3
Yaip, C.4
Parbaharan, H.5
Thompson, P.6
-
155
-
-
84862800391
-
Synthesis and Structure-Activity Relationships of Imidazo[1,2- A ]pyrimidin-5(1 H)-ones as a Novel Series of Beta Isoform Selective Phosphatidylinositol 3-Kinase Inhibitors
-
Lin, H.; Erhard, K.; Hardwicke, M. A.; Luengo, J. I.; Mack, J. F.; McSurdy-Freed, J.; Plant, R.; Raha, K.; Rominger, C. M.; Sanchez, R. M.; Schaber, M. D.; Schulz, M. J.; Spengler, M. D.; Tedesco, R.; Xie, R.; Zeng, J. J.; Rivero, R. A. Synthesis and Structure-Activity Relationships of Imidazo[1,2- a ]pyrimidin-5(1 H)-ones as a Novel Series of Beta Isoform Selective Phosphatidylinositol 3-Kinase Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 2230-2234
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 2230-2234
-
-
Lin, H.1
Erhard, K.2
Hardwicke, M.A.3
Luengo, J.I.4
Mack, J.F.5
McSurdy-Freed, J.6
Plant, R.7
Raha, K.8
Rominger, C.M.9
Sanchez, R.M.10
Schaber, M.D.11
Schulz, M.J.12
Spengler, M.D.13
Tedesco, R.14
Xie, R.15
Zeng, J.J.16
Rivero, R.A.17
-
156
-
-
21044454703
-
PI 3-Kinase p110beta: A New Target for Antithrombotic Therapy
-
Jackson, S. P.; Schoenwaelder, S. M.; Goncalves, I.; Nesbitt, W. S.; Yap, C. L.; Wright, C. E.; Kenche, V.; Anderson, K. E.; Dopheide, S. M.; Yuan, Y.; Sturgeon, S. A.; Prabaharan, H.; Thompson, P. E.; Smith, G. D.; Shepherd, P. R.; Daniele, N.; Kulkarni, S.; Abbott, B.; Saylik, D.; Jones, C.; Lu, L.; Giuliano, S.; Hughan, S. C.; Angus, J. A.; Robertson, A. D.; Salem, H. H. PI 3-Kinase p110beta: A New Target for Antithrombotic Therapy Nat. Med. 2005, 11, 507-514
-
(2005)
Nat. Med.
, vol.11
, pp. 507-514
-
-
Jackson, S.P.1
Schoenwaelder, S.M.2
Goncalves, I.3
Nesbitt, W.S.4
Yap, C.L.5
Wright, C.E.6
Kenche, V.7
Anderson, K.E.8
Dopheide, S.M.9
Yuan, Y.10
Sturgeon, S.A.11
Prabaharan, H.12
Thompson, P.E.13
Smith, G.D.14
Shepherd, P.R.15
Daniele, N.16
Kulkarni, S.17
Abbott, B.18
Saylik, D.19
Jones, C.20
Lu, L.21
Giuliano, S.22
Hughan, S.C.23
Angus, J.A.24
Robertson, A.D.25
Salem, H.H.26
more..
-
157
-
-
84863833204
-
Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110 as a Potential Anticancer Agent
-
Ni, J.; Liu, Q.; Xie, S.; Carlson, C.; Von, T.; Vogel, K.; Riddle, S.; Benes, C.; Eck, M.; Roberts, T.; Gray, N.; Zhao, J. Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110as a Potential Anticancer Agent Cancer Discovery 2012, 2, 425-433
-
(2012)
Cancer Discovery
, vol.2
, pp. 425-433
-
-
Ni, J.1
Liu, Q.2
Xie, S.3
Carlson, C.4
Von, T.5
Vogel, K.6
Riddle, S.7
Benes, C.8
Eck, M.9
Roberts, T.10
Gray, N.11
Zhao, J.12
-
158
-
-
84866876711
-
Human Target Validation of Phosphoinositide 3-Kinase (PI3K): Effects on Platelets and Insulin Sensitivity, Using AZD6482 a Novel PI3K Inhibitor
-
Nylander, S.; Kull, B.; Björkman, J. A.; Ulvinge, J. C.; Oakes, N.; Emanuelsson, B. M.; Andersson, M.; Skärby, T.; Inghardt, T.; Fjellström, O.; Gustafsson, D. Human Target Validation of Phosphoinositide 3-Kinase (PI3K): Effects on Platelets and Insulin Sensitivity, Using AZD6482 a Novel PI3KInhibitor J. Thromb. Haemostasis 2012, 10, 2127-2136
-
(2012)
J. Thromb. Haemostasis
, vol.10
, pp. 2127-2136
-
-
Nylander, S.1
Kull, B.2
Björkman, J.A.3
Ulvinge, J.C.4
Oakes, N.5
Emanuelsson, B.M.6
Andersson, M.7
Skärby, T.8
Inghardt, T.9
Fjellström, O.10
Gustafsson, D.11
-
159
-
-
84859826350
-
Synthesis and Structure-Activity Relationships of 1,2,4-Triazolo[1,5-A]pyrimidin-7(3 H)-ones as Novel Series of Potent B Isoform Selective Phosphatidylinositol 3-Kinase Inhibitors
-
Sanchez, R. M.; Erhard, K.; Hardwicke, M. A.; Lin, H.; McSurdy-Freed, J.; Plant, R.; Raha, K.; Rominger, C. M.; Schaber, M. D.; Spengler, M. D.; Moore, M. L.; Yu, H.; Luengo, J. I.; Tedesco, R.; Rivero, R. A. Synthesis and Structure-Activity Relationships of 1,2,4-Triazolo[1,5-a]pyrimidin-7(3 H)-ones as Novel Series of Potent B Isoform Selective Phosphatidylinositol 3-Kinase Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 3198-3202
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 3198-3202
-
-
Sanchez, R.M.1
Erhard, K.2
Hardwicke, M.A.3
Lin, H.4
McSurdy-Freed, J.5
Plant, R.6
Raha, K.7
Rominger, C.M.8
Schaber, M.D.9
Spengler, M.D.10
Moore, M.L.11
Yu, H.12
Luengo, J.I.13
Tedesco, R.14
Rivero, R.A.15
-
160
-
-
84875143933
-
Identification of GSK2636771, a Potent and Selective, Orally Bioavailable Inhibitor of Phosphatidylinositol 3-Kinase-Beta (PI3K) for the Treatment of PTEN Deficient Tumors
-
(Proceedings of American Association for Cancer Research, 103rd Annual Meeting, Chicago IL, Mar 31-Apr 4, 2012).
-
Rivero, R. A.; Hardwicke, M. A. Identification of GSK2636771, a Potent and Selective, Orally Bioavailable Inhibitor of Phosphatidylinositol 3-Kinase-Beta (PI3K) for the Treatment of PTEN Deficient Tumors. (Proceedings of American Association for Cancer Research, 103rd Annual Meeting, Chicago IL, Mar 31-Apr 4, 2012) Cancer Res. 2012, 72, Abstract 2913.
-
(2012)
Cancer Res.
, vol.72
, pp. 2913
-
-
Rivero, R.A.1
Hardwicke, M.A.2
-
161
-
-
84938765398
-
A Phase I/II, First-in-Human Dose-Escalation Study of GSK2636771 in Patients (pts) with PTEN-Deficient Advanced Tumors
-
Arkenau, H.-T.; Mateo, J.; Lemech, C. R.; Infante, J. R.; Burris, H. A.; Bang, Y.-J.; Eder, J. P.; Herbst, R. S.; Sharma, S.; Chung, H. C.; Decordova, S.; Swales, K. E.; Garret, M. D.; Loftiss, J. I.; Durante, M.; Russo, M. W.; Suttle, B. B.; Motwani, M.; Kumar, R.; De Bono, J. S.; Cannon, S. A Phase I/II, First-in-Human Dose-Escalation Study of GSK2636771 in Patients (pts) with PTEN-Deficient Advanced Tumors. J. Clin. Oncol. 2014, 32, Abstract 2514.
-
(2014)
J. Clin. Oncol.
, vol.32
, pp. 2514
-
-
Arkenau, H.-T.1
Mateo, J.2
Lemech, C.R.3
Infante, J.R.4
Burris, H.A.5
Bang, Y.-J.6
Eder, J.P.7
Herbst, R.S.8
Sharma, S.9
Chung, H.C.10
Decordova, S.11
Swales, K.E.12
Garret, M.D.13
Loftiss, J.I.14
Durante, M.15
Russo, M.W.16
Suttle, B.B.17
Motwani, M.18
Kumar, R.19
De Bono, J.S.20
Cannon, S.21
more..
-
162
-
-
84863845246
-
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-Beta Inhibitors
-
Lin, H.; Schulz, M. J.; Xie, R.; Zeng, J.; Luengo, J. I.; Squire, M. D.; Tedesco, R.; Qu, J.; Erhard, K.; Mack, J. F.; Raha, K.; Plant, R.; Rominger, C. M.; Ariazi, J. L.; Sherk, C. S.; Schaber, M. D.; McSurdy-Freed, J.; Spengler, M. D.; Davis, C. B.; Hardwicke, M. A.; Rivero, R. A. Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-Beta Inhibitors ACS Med. Chem. Lett. 2012, 3, 524-529
-
(2012)
ACS Med. Chem. Lett.
, vol.3
, pp. 524-529
-
-
Lin, H.1
Schulz, M.J.2
Xie, R.3
Zeng, J.4
Luengo, J.I.5
Squire, M.D.6
Tedesco, R.7
Qu, J.8
Erhard, K.9
Mack, J.F.10
Raha, K.11
Plant, R.12
Rominger, C.M.13
Ariazi, J.L.14
Sherk, C.S.15
Schaber, M.D.16
McSurdy-Freed, J.17
Spengler, M.D.18
Davis, C.B.19
Hardwicke, M.A.20
Rivero, R.A.21
more..
-
163
-
-
84875139575
-
Synthesis and Cancer Stem Cell-Based Activity of Substituted 5-Morpholino-7 H -thieno[3,2- b ]pyran-7-ones Designed as Next Generation PI3K Inhibitors
-
Morales, G. A.; Garlich, J. R.; Su, J.; Peng, X.; Newblom, J.; Weber, K.; Durden, D. L. Synthesis and Cancer Stem Cell-Based Activity of Substituted 5-Morpholino-7 H -thieno[3,2- b ]pyran-7-ones Designed as Next Generation PI3K Inhibitors J. Med. Chem. 2013, 56, 1922-1939
-
(2013)
J. Med. Chem.
, vol.56
, pp. 1922-1939
-
-
Morales, G.A.1
Garlich, J.R.2
Su, J.3
Peng, X.4
Newblom, J.5
Weber, K.6
Durden, D.L.7
-
164
-
-
78651258569
-
Discovery of Novel Class 1 Phosphatidylinositide 3-Kinases (PI3K) Fragment Inhibitors through Structure-Based Virtual Screening
-
Giordanetto, F.; Kull, B.; Dellsén, A. Discovery of Novel Class 1 Phosphatidylinositide 3-Kinases (PI3K) Fragment Inhibitors through Structure-Based Virtual Screening Bioorg. Med. Chem. Lett. 2011, 21, 829-835
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 829-835
-
-
Giordanetto, F.1
Kull, B.2
Dellsén, A.3
-
165
-
-
84867578803
-
Discovery of 4-Morpholino-pyrimidin-6-one and 4-Morpholino-pyrimidin-2-one-Containing Phosphoinositide 3-Kinase (PI3K) p110 Isoform Inhibitors through Structure-Based Fragment Optimisation
-
Giordanetto, F.; Wållberg, A.; Cassel, J.; Ghosal, S.; Kossenjans, M.; Yuan, Z.-Q.; Wang, X.; Liang, L. Discovery of 4-Morpholino-pyrimidin-6-one and 4-Morpholino-pyrimidin-2-one-Containing Phosphoinositide 3-Kinase (PI3K) p110 Isoform Inhibitors through Structure-Based Fragment Optimisation Bioorg. Med. Chem. Lett. 2012, 22, 6665-6670
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 6665-6670
-
-
Giordanetto, F.1
Wållberg, A.2
Cassel, J.3
Ghosal, S.4
Kossenjans, M.5
Yuan, Z.-Q.6
Wang, X.7
Liang, L.8
-
166
-
-
84866732699
-
Preparation and Optimization of New 4-(Morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide Derivatives as PI3K Inhibitors
-
Certal, V.; Halley, F.; Virone-Oddos, A.; Thompson, F.; Filoche-Rommé, B.; El-Ahmad, Y.; Carry, J.-C.; Delorme, C.; Karlsson, A.; Abecassis, P.-Y.; Vincent, L.; Bonnevaux, H.; Nicolas, J.-P.; Morales, R.; Michot, N.; Vade, I.; Louboutin, A.; Perron, S.; Doerflinger, G.; Tric, B.; Monget, S.; Lengauer, C.; Schio, L. Preparation and Optimization of New 4-(Morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide Derivatives as PI3K Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 6381-6384
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 6381-6384
-
-
Certal, V.1
Halley, F.2
Virone-Oddos, A.3
Thompson, F.4
Filoche-Rommé, B.5
El-Ahmad, Y.6
Carry, J.-C.7
Delorme, C.8
Karlsson, A.9
Abecassis, P.-Y.10
Vincent, L.11
Bonnevaux, H.12
Nicolas, J.-P.13
Morales, R.14
Michot, N.15
Vade, I.16
Louboutin, A.17
Perron, S.18
Doerflinger, G.19
Tric, B.20
Monget, S.21
Lengauer, C.22
Schio, L.23
more..
-
167
-
-
84861490514
-
Discovery and Optimization of New Benzimidazole- and Benzoxazole-pyrimidone Selective PI3K Inhibitors for the Treatment of Phosphatase and TENsin Homologue (PTEN)-Deficient Cancers
-
Certal, V.; Halley, F.; Virone-Oddos, A.; Delorme, C.; Karlsson, A.; Rak, A.; Thompson, F.; Filoche-Rommé, B.; El-Ahmad, Y.; Carry, J.-C.; Abecassis, P.-Y.; Lejeune, P.; Vincent, L.; Bonnevaux, H.; Nicolas, J.-P.; Bertrand, T.; Marquette, J.-P.; Michot, N.; Benard, T.; Below, P.; Vade, I.; Chatreaux, F.; Lebourg, G.; Pilorge, F.; Angouillant-Boniface, O.; Louboutin, A.; Lengauer, C.; Schio, L. Discovery and Optimization of New Benzimidazole- and Benzoxazole-pyrimidone Selective PI3K Inhibitors for the Treatment of Phosphatase and TENsin Homologue (PTEN)-Deficient Cancers J. Med. Chem. 2012, 55, 4788-4805
-
(2012)
J. Med. Chem.
, vol.55
, pp. 4788-4805
-
-
Certal, V.1
Halley, F.2
Virone-Oddos, A.3
Delorme, C.4
Karlsson, A.5
Rak, A.6
Thompson, F.7
Filoche-Rommé, B.8
El-Ahmad, Y.9
Carry, J.-C.10
Abecassis, P.-Y.11
Lejeune, P.12
Vincent, L.13
Bonnevaux, H.14
Nicolas, J.-P.15
Bertrand, T.16
Marquette, J.-P.17
Michot, N.18
Benard, T.19
Below, P.20
Vade, I.21
Chatreaux, F.22
Lebourg, G.23
Pilorge, F.24
Angouillant-Boniface, O.25
Louboutin, A.26
Lengauer, C.27
Schio, L.28
more..
-
168
-
-
84894084021
-
Discovery and Optimization of Pyrimidone Indoline Amide PI3K Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers
-
Certal, V.; Carry, J.-C.; Halley, F.; Virone-Oddos, A.; Thompson, F.; Filoche-Rommé, B.; El-Ahmad, Y.; Karlsson, A.; Charrier, V.; Delorme, C.; Rak, A.; Abecassis, P.-Y.; Amara, C.; Vincent, L.; Bonnevaux, H.; Nicolas, J.-P.; Mathieu, M.; Bertrand, T.; Marquette, J.-P.; Michot, N.; Benard, T.; Perrin, M.-A.; Lemaitre, O.; Guerif, S.; Perron, S.; Monget, S.; Gruss-Leleu, F.; Doerflinger, G.; Guizani, H.; Brollo, M.; Delbarre, L.; Bertin, L.; Richepin, P.; Loyau, V.; Garcia-Echeverria, C.; Lengauer, C.; Schio, L. Discovery and Optimization of Pyrimidone Indoline Amide PI3K Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers J. Med. Chem. 2014, 57, 903-920
-
(2014)
J. Med. Chem.
, vol.57
, pp. 903-920
-
-
Certal, V.1
Carry, J.-C.2
Halley, F.3
Virone-Oddos, A.4
Thompson, F.5
Filoche-Rommé, B.6
El-Ahmad, Y.7
Karlsson, A.8
Charrier, V.9
Delorme, C.10
Rak, A.11
Abecassis, P.-Y.12
Amara, C.13
Vincent, L.14
Bonnevaux, H.15
Nicolas, J.-P.16
Mathieu, M.17
Bertrand, T.18
Marquette, J.-P.19
Michot, N.20
Benard, T.21
Perrin, M.-A.22
Lemaitre, O.23
Guerif, S.24
Perron, S.25
Monget, S.26
Gruss-Leleu, F.27
Doerflinger, G.28
Guizani, H.29
Brollo, M.30
Delbarre, L.31
Bertin, L.32
Richepin, P.33
Loyau, V.34
Garcia-Echeverria, C.35
Lengauer, C.36
Schio, L.37
more..
-
169
-
-
33748096426
-
Synthesis and Biological Evaluation of 4-Morpholino-2-phenylquinazolines and Related Derivatives as Novel PI3 Kinase p110alpha Inhibitors
-
Hayakawa, M.; Kaizawa, H.; Moritomo, H.; Koizumi, T.; Ohishi, T.; Okada, M.; Ohta, M.; Tsukamoto, S.; Parker, P.; Workman, P.; Waterfield, M. Synthesis and Biological Evaluation of 4-Morpholino-2-phenylquinazolines and Related Derivatives as Novel PI3 Kinase p110alpha Inhibitors Bioorg. Med. Chem. 2006, 14, 6847-6858
-
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 6847-6858
-
-
Hayakawa, M.1
Kaizawa, H.2
Moritomo, H.3
Koizumi, T.4
Ohishi, T.5
Okada, M.6
Ohta, M.7
Tsukamoto, S.8
Parker, P.9
Workman, P.10
Waterfield, M.11
-
170
-
-
33750953816
-
Synthesis and Biological Evaluation of imidazo[1,2-A]pyridine Derivatives as Novel PI3 Kinase p110alpha Inhibitors
-
Hayakawa, M.; Kaizawa, H.; Kawaguchi, K.-I.; Ishikawa, N.; Koizumi, T.; Ohishi, T.; Yamano, M.; Okada, M.; Ohta, M.; Tsukamoto, S.-I.; Raynaud, F. I.; Waterfield, M. D.; Parker, P.; Workman, P. Synthesis and Biological Evaluation of imidazo[1,2-a]pyridine Derivatives as Novel PI3 Kinase p110alpha Inhibitors Bioorg. Med. Chem. 2007, 15, 403-412
-
(2007)
Bioorg. Med. Chem.
, vol.15
, pp. 403-412
-
-
Hayakawa, M.1
Kaizawa, H.2
Kawaguchi, K.-I.3
Ishikawa, N.4
Koizumi, T.5
Ohishi, T.6
Yamano, M.7
Okada, M.8
Ohta, M.9
Tsukamoto, S.-I.10
Raynaud, F.I.11
Waterfield, M.D.12
Parker, P.13
Workman, P.14
-
171
-
-
33947730475
-
Synthesis and Biological Evaluation of pyrido[324,5]furo[3,2-d]pyrimidine Derivatives as Novel PI3 Kinase p110alpha Inhibitors
-
Hayakawa, M.; Kaizawa, H.; Moritomo, H.; Koizumi, T.; Ohishi, T.; Yamano, M.; Okada, M.; Ohta, M.; Tsukamoto, S.; Raynaud, F. I.; Workman, P.; Waterfield, M. D.; Parker, P. Synthesis and Biological Evaluation of pyrido[324,5]furo[3,2-d]pyrimidine Derivatives as Novel PI3 Kinase p110alpha Inhibitors Bioorg. Med. Chem. Lett. 2007, 17, 2438-2442
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 2438-2442
-
-
Hayakawa, M.1
Kaizawa, H.2
Moritomo, H.3
Koizumi, T.4
Ohishi, T.5
Yamano, M.6
Okada, M.7
Ohta, M.8
Tsukamoto, S.9
Raynaud, F.I.10
Workman, P.11
Waterfield, M.D.12
Parker, P.13
-
172
-
-
52449106253
-
The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class i PI3 Kinase for the Treatment of Cancer
-
Folkes, A. J.; Ahmadi, K.; Alderton, W. K.; Alix, S.; Baker, S. J.; Box, G.; Chuckowree, I. S.; Clarke, P. A.; Depledge, P.; Eccles, S. A.; Friedman, L. S.; Hayes, A.; Hancox, T. C.; Kugendradas, A.; Lensun, L.; Moore, P.; Olivero, A. G.; Pang, J.; Patel, S.; Pergl-Wilson, G. H.; Raynaud, F. I.; Robson, A.; Saghir, N.; Salphati, L.; Sohal, S.; Ultsch, M. H.; Valenti, M.; Wallweber, H. J. A.; Wan, N. C.; Wiesmann, C.; Workman, P.; Zhyvoloup, A.; Zvelebil, M. J.; Shuttleworth, S. J. The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer J. Med. Chem. 2008, 51, 5522-5532
-
(2008)
J. Med. Chem.
, vol.51
, pp. 5522-5532
-
-
Folkes, A.J.1
Ahmadi, K.2
Alderton, W.K.3
Alix, S.4
Baker, S.J.5
Box, G.6
Chuckowree, I.S.7
Clarke, P.A.8
Depledge, P.9
Eccles, S.A.10
Friedman, L.S.11
Hayes, A.12
Hancox, T.C.13
Kugendradas, A.14
Lensun, L.15
Moore, P.16
Olivero, A.G.17
Pang, J.18
Patel, S.19
Pergl-Wilson, G.H.20
Raynaud, F.I.21
Robson, A.22
Saghir, N.23
Salphati, L.24
Sohal, S.25
Ultsch, M.H.26
Valenti, M.27
Wallweber, H.J.A.28
Wan, N.C.29
Wiesmann, C.30
Workman, P.31
Zhyvoloup, A.32
Zvelebil, M.J.33
Shuttleworth, S.J.34
more..
-
173
-
-
33646382364
-
A Dual PI3 Kinase/mTOR Inhibitor Reveals Emergent Efficacy in Glioma
-
Fan, Q.-W.; Knight, Z. A.; Goldenberg, D. D.; Yu, W.; Mostov, K. E.; Stokoe, D.; Shokat, K. M.; Weiss, W. A. A Dual PI3 Kinase/mTOR Inhibitor Reveals Emergent Efficacy in Glioma Cancer Cell 2006, 9, 341-349
-
(2006)
Cancer Cell
, vol.9
, pp. 341-349
-
-
Fan, Q.-W.1
Knight, Z.A.2
Goldenberg, D.D.3
Yu, W.4
Mostov, K.E.5
Stokoe, D.6
Shokat, K.M.7
Weiss, W.A.8
-
174
-
-
34250823572
-
Pharmacologic Characterization of a Potent Inhibitor of Class i Phosphatidylinositide 3-Kinases
-
Raynaud, F. I.; Eccles, S.; Clarke, P. A.; Hayes, A.; Nutley, B.; Alix, S.; Henley, A.; Di-Stefano, F.; Ahmad, Z.; Guillard, S.; Bjerke, L. M.; Kelland, L.; Valenti, M.; Patterson, L.; Gowan, S.; Brandon, A.; de, H.; Hayakawa, M.; Kaizawa, H.; Koizumi, T.; Ohishi, T.; Patel, S.; Saghir, N.; Parker, P.; Waterfield, M.; Workman, P. Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases Cancer Res. 2007, 67, 5840-5850
-
(2007)
Cancer Res.
, vol.67
, pp. 5840-5850
-
-
Raynaud, F.I.1
Eccles, S.2
Clarke, P.A.3
Hayes, A.4
Nutley, B.5
Alix, S.6
Henley, A.7
Di-Stefano, F.8
Ahmad, Z.9
Guillard, S.10
Bjerke, L.M.11
Kelland, L.12
Valenti, M.13
Patterson, L.14
Gowan, S.15
Brandon, A.16
De, H.17
Hayakawa, M.18
Kaizawa, H.19
Koizumi, T.20
Ohishi, T.21
Patel, S.22
Saghir, N.23
Parker, P.24
Waterfield, M.25
Workman, P.26
more..
-
175
-
-
84655164332
-
Discovery and Bioactivity of 4-(2-Arylpyrido[32:3,4]pyrrolo[1,2- f ][1,2,4]-triazin-4-yl) Morpholine Derivatives as Novel PI3K Inhibitors
-
Wang, J.; Wang, X.; Chen, Y.; Chen, S.; Chen, G.; Tong, L.; Meng, L.; Xie, Y.; Ding, J.; Yang, C. Discovery and Bioactivity of 4-(2-Arylpyrido[3,2:3,4]pyrrolo[1,2- f ][1,2,4]-triazin-4-yl) Morpholine Derivatives as Novel PI3K Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 339-342
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 339-342
-
-
Wang, J.1
Wang, X.2
Chen, Y.3
Chen, S.4
Chen, G.5
Tong, L.6
Meng, L.7
Xie, Y.8
Ding, J.9
Yang, C.10
-
176
-
-
67651155960
-
Biological Properties of Potent Inhibitors of Class i Phosphatidylinositide 3-Kinases: From PI-103 through PI-540, PI-620 to the Oral Agent GDC-0941
-
Raynaud, F. I.; Eccles, S. A.; Patel, S.; Alix, S.; Box, G.; Chuckowree, I.; Folkes, A.; Gowan, S.; De Haven Brandon, A.; Di Stefano, F.; Hayes, A.; Henley, A. T.; Lensun, L.; Pergl-Wilson, G.; Robson, A.; Saghir, N.; Zhyvoloup, A.; McDonald, E.; Sheldrake, P.; Shuttleworth, S.; Valenti, M.; Wan, N. C.; Clarke, P. A.; Workman, P. Biological Properties of Potent Inhibitors of Class I Phosphatidylinositide 3-Kinases: From PI-103 through PI-540, PI-620 to the Oral Agent GDC-0941 Mol. Cancer Ther. 2009, 8, 1725-1738
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 1725-1738
-
-
Raynaud, F.I.1
Eccles, S.A.2
Patel, S.3
Alix, S.4
Box, G.5
Chuckowree, I.6
Folkes, A.7
Gowan, S.8
De Haven Brandon, A.9
Di Stefano, F.10
Hayes, A.11
Henley, A.T.12
Lensun, L.13
Pergl-Wilson, G.14
Robson, A.15
Saghir, N.16
Zhyvoloup, A.17
McDonald, E.18
Sheldrake, P.19
Shuttleworth, S.20
Valenti, M.21
Wan, N.C.22
Clarke, P.A.23
Workman, P.24
more..
-
177
-
-
77950048995
-
Identification of GNE-477, a Potent and Efficacious Dual PI3K/mTOR Inhibitor
-
Heffron, T. P.; Berry, M.; Castanedo, G.; Chang, C.; Chuckowree, I.; Dotson, J.; Folkes, A.; Gunzner, J.; Lesnick, J. D.; Lewis, C.; Mathieu, S.; Nonomiya, J.; Olivero, A.; Pang, J.; Peterson, D.; Salphati, L.; Sampath, D.; Sideris, S.; Sutherlin, D. P.; Tsui, V.; Wan, N. C.; Wang, S.; Wong, S.; Zhu, B.-Y. Identification of GNE-477, a Potent and Efficacious Dual PI3K/mTOR Inhibitor Bioorg. Med. Chem. Lett. 2010, 20, 2408-2411
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 2408-2411
-
-
Heffron, T.P.1
Berry, M.2
Castanedo, G.3
Chang, C.4
Chuckowree, I.5
Dotson, J.6
Folkes, A.7
Gunzner, J.8
Lesnick, J.D.9
Lewis, C.10
Mathieu, S.11
Nonomiya, J.12
Olivero, A.13
Pang, J.14
Peterson, D.15
Salphati, L.16
Sampath, D.17
Sideris, S.18
Sutherlin, D.P.19
Tsui, V.20
Wan, N.C.21
Wang, S.22
Wong, S.23
Zhu, B.-Y.24
more..
-
178
-
-
80455140538
-
Discovery of a Potent, Selective, and Orally Available Class i Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
-
Sutherlin, D. P.; Bao, L.; Berry, M.; Castanedo, G.; Chuckowree, I.; Dotson, J.; Folks, A.; Friedman, L.; Goldsmith, R.; Gunzner, J.; Heffron, T.; Lesnick, J.; Lewis, C.; Mathieu, S.; Murray, J.; Nonomiya, J.; Pang, J.; Pegg, N.; Prior, W. W.; Rouge, L.; Salphati, L.; Sampath, D.; Tian, Q.; Tsui, V.; Wan, N. C.; Wang, S.; Wei, B.; Wiesmann, C.; Wu, P.; Zhu, B.-Y.; Olivero, A. Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer J. Med. Chem. 2011, 54, 7579-7587
-
(2011)
J. Med. Chem.
, vol.54
, pp. 7579-7587
-
-
Sutherlin, D.P.1
Bao, L.2
Berry, M.3
Castanedo, G.4
Chuckowree, I.5
Dotson, J.6
Folks, A.7
Friedman, L.8
Goldsmith, R.9
Gunzner, J.10
Heffron, T.11
Lesnick, J.12
Lewis, C.13
Mathieu, S.14
Murray, J.15
Nonomiya, J.16
Pang, J.17
Pegg, N.18
Prior, W.W.19
Rouge, L.20
Salphati, L.21
Sampath, D.22
Tian, Q.23
Tsui, V.24
Wan, N.C.25
Wang, S.26
Wei, B.27
Wiesmann, C.28
Wu, P.29
Zhu, B.-Y.30
Olivero, A.31
more..
-
179
-
-
77249137785
-
Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-kinase/mTOR Inhibitors for the Treatment of Cancer
-
Sutherlin, D. P.; Sampath, D.; Berry, M.; Castanedo, G.; Chang, Z.; Chuckowree, I.; Dotson, J.; Folkes, A.; Friedman, L.; Goldsmith, R.; Heffron, T.; Lee, L.; Lesnick, J.; Lewis, C.; Mathieu, S.; Nonomiya, J.; Olivero, A.; Pang, J.; Prior, W. W.; Salphati, L.; Sideris, S.; Tian, Q.; Tsui, V.; Wan, N. C.; Wang, S.; Wiesmann, C.; Wong, S.; Zhu, B.-Y. Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-kinase/mTOR Inhibitors for the Treatment of Cancer J. Med. Chem. 2010, 53, 1086-1097
-
(2010)
J. Med. Chem.
, vol.53
, pp. 1086-1097
-
-
Sutherlin, D.P.1
Sampath, D.2
Berry, M.3
Castanedo, G.4
Chang, Z.5
Chuckowree, I.6
Dotson, J.7
Folkes, A.8
Friedman, L.9
Goldsmith, R.10
Heffron, T.11
Lee, L.12
Lesnick, J.13
Lewis, C.14
Mathieu, S.15
Nonomiya, J.16
Olivero, A.17
Pang, J.18
Prior, W.W.19
Salphati, L.20
Sideris, S.21
Tian, Q.22
Tsui, V.23
Wan, N.C.24
Wang, S.25
Wiesmann, C.26
Wong, S.27
Zhu, B.-Y.28
more..
-
180
-
-
84865192520
-
Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human
-
Salphati, L.; Pang, J.; Plise, E. G.; Lee, L. B.; Olivero, A. G.; Prior, W. W.; Sampath, D.; Wong, S.; Zhang, X. Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human Drug Metab. Dispos. 2012, 40, 1785-1796
-
(2012)
Drug Metab. Dispos.
, vol.40
, pp. 1785-1796
-
-
Salphati, L.1
Pang, J.2
Plise, E.G.3
Lee, L.B.4
Olivero, A.G.5
Prior, W.W.6
Sampath, D.7
Wong, S.8
Zhang, X.9
-
181
-
-
84862167093
-
Potent and Selective Inhibitors of PI3K: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf
-
Sutherlin, D. P.; Baker, S.; Bisconte, A.; Blaney, P. M.; Brown, A.; Chan, B. K.; Chantry, D.; Castanedo, G.; DePledge, P.; Goldsmith, P.; Goldstein, D. M.; Hancox, T.; Kaur, J.; Knowles, D.; Kondru, R.; Lesnick, J.; Lucas, M. C.; Lewis, C.; Murray, J.; Nadin, A. J.; Nonomiya, J.; Pang, J.; Pegg, N.; Price, S.; Reif, K.; Safina, B. S.; Salphati, L.; Staben, S.; Seward, E. M.; Shuttleworth, S.; Sohal, S.; Sweeney, Z. K.; Ultsch, M.; Waszkowycz, B.; Wei, B. Potent and Selective Inhibitors of PI3K: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf Bioorg. Med. Chem. Lett. 2012, 22, 4296-4302
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 4296-4302
-
-
Sutherlin, D.P.1
Baker, S.2
Bisconte, A.3
Blaney, P.M.4
Brown, A.5
Chan, B.K.6
Chantry, D.7
Castanedo, G.8
Depledge, P.9
Goldsmith, P.10
Goldstein, D.M.11
Hancox, T.12
Kaur, J.13
Knowles, D.14
Kondru, R.15
Lesnick, J.16
Lucas, M.C.17
Lewis, C.18
Murray, J.19
Nadin, A.J.20
Nonomiya, J.21
Pang, J.22
Pegg, N.23
Price, S.24
Reif, K.25
Safina, B.S.26
Salphati, L.27
Staben, S.28
Seward, E.M.29
Shuttleworth, S.30
Sohal, S.31
Sweeney, Z.K.32
Ultsch, M.33
Waszkowycz, B.34
Wei, B.35
more..
-
182
-
-
84863092387
-
Discovery of Novel PI3-Kinase Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition
-
Safina, B. S.; Baker, S.; Baumgardner, M.; Blaney, P. M.; Chan, B. K.; Chen, Y.-H.; Cartwright, M. W.; Castanedo, G.; Chabot, C.; Cheguillaume, A. J.; Goldsmith, P.; Goldstein, D. M.; Goyal, B.; Hancox, T.; Handa, R. K.; Iyer, P. S.; Kaur, J.; Kondru, R.; Kenny, J. R.; Krintel, S. L.; Li, J.; Lesnick, J.; Lucas, M. C.; Lewis, C.; Mukadam, S.; Murray, J.; Nadin, A. J.; Nonomiya, J.; Padilla, F.; Palmer, W. S.; Pang, J.; Pegg, N.; Price, S.; Reif, K.; Salphati, L.; Savy, P. A.; Seward, E. M.; Shuttleworth, S.; Sohal, S.; Sweeney, Z. K.; Tay, S.; Tivitmahaisoon, P.; Waszkowycz, B.; Wei, B.; Yue, Q.; Zhang, C.; Sutherlin, D. P. Discovery of Novel PI3-Kinase Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition J. Med. Chem. 2012, 55, 5887-5900
-
(2012)
J. Med. Chem.
, vol.55
, pp. 5887-5900
-
-
Safina, B.S.1
Baker, S.2
Baumgardner, M.3
Blaney, P.M.4
Chan, B.K.5
Chen, Y.-H.6
Cartwright, M.W.7
Castanedo, G.8
Chabot, C.9
Cheguillaume, A.J.10
Goldsmith, P.11
Goldstein, D.M.12
Goyal, B.13
Hancox, T.14
Handa, R.K.15
Iyer, P.S.16
Kaur, J.17
Kondru, R.18
Kenny, J.R.19
Krintel, S.L.20
Li, J.21
Lesnick, J.22
Lucas, M.C.23
Lewis, C.24
Mukadam, S.25
Murray, J.26
Nadin, A.J.27
Nonomiya, J.28
Padilla, F.29
Palmer, W.S.30
Pang, J.31
Pegg, N.32
Price, S.33
Reif, K.34
Salphati, L.35
Savy, P.A.36
Seward, E.M.37
Shuttleworth, S.38
Sohal, S.39
Sweeney, Z.K.40
Tay, S.41
Tivitmahaisoon, P.42
Waszkowycz, B.43
Wei, B.44
Yue, Q.45
Zhang, C.46
Sutherlin, D.P.47
more..
-
183
-
-
84866309700
-
Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta
-
Murray, J. M.; Sweeney, Z. K.; Chan, B. K.; Balazs, M.; Bradley, E.; Castanedo, G.; Chabot, C.; Chantry, D.; Flagella, M.; Goldstein, D. M.; Kondru, R.; Lesnick, J.; Li, J.; Lucas, M. C.; Nonomiya, J.; Pang, J.; Price, S.; Salphati, L.; Safina, B.; Savy, P. P. A.; Seward, E. M.; Ultsch, M.; Sutherlin, D. P. Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta J. Med. Chem. 2012, 55, 7686-7695
-
(2012)
J. Med. Chem.
, vol.55
, pp. 7686-7695
-
-
Murray, J.M.1
Sweeney, Z.K.2
Chan, B.K.3
Balazs, M.4
Bradley, E.5
Castanedo, G.6
Chabot, C.7
Chantry, D.8
Flagella, M.9
Goldstein, D.M.10
Kondru, R.11
Lesnick, J.12
Li, J.13
Lucas, M.C.14
Nonomiya, J.15
Pang, J.16
Price, S.17
Salphati, L.18
Safina, B.19
Savy, P.P.A.20
Seward, E.M.21
Ultsch, M.22
Sutherlin, D.P.23
more..
-
184
-
-
84881373454
-
Identification of GNE-293, a Potent and Selective PI3KInhibitor: Navigating in Vitro Genotoxicity while Improving Potency and Selectivity
-
Safina, B. S.; Sweeney, Z. K.; Li, J.; Chan, B. K.; Bisconte, A.; Carrera, D.; Castanedo, G.; Flagella, M.; Heald, R.; Lewis, C.; Murray, J. M.; Nonomiya, J.; Pang, J.; Price, S.; Reif, K.; Salphati, L.; Seward, E. M.; Wei, B.; Sutherlin, D. P. Identification of GNE-293, a Potent and Selective PI3K Inhibitor: Navigating in Vitro Genotoxicity While Improving Potency and Selectivity Bioorg. Med. Chem. Lett. 2013, 23, 4953-4959
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, pp. 4953-4959
-
-
Safina, B.S.1
Sweeney, Z.K.2
Li, J.3
Chan, B.K.4
Bisconte, A.5
Carrera, D.6
Castanedo, G.7
Flagella, M.8
Heald, R.9
Lewis, C.10
Murray, J.M.11
Nonomiya, J.12
Pang, J.13
Price, S.14
Reif, K.15
Salphati, L.16
Seward, E.M.17
Wei, B.18
Sutherlin, D.P.19
-
185
-
-
84857373390
-
Imidazo[1,2-A]pyrazines as Novel PI3K Inhibitors
-
Martinez González, S.; Hernández, A. I.; Varela, C.; Rodriguez-Aristegui, S.; Alvarez, R. M.; Garcí;a, A. B.; Lorenzo, M.; Rivero, V.; Oyarzabal, J.; Rabal, O.; Bischoff, J. R.; Albarrán, M.; Cebriá, A.; Alfonso, P.; Link, W.; Fominaya, J.; Pastor, J. Imidazo[1,2-a]pyrazines as Novel PI3K Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 1874-1878
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 1874-1878
-
-
Martinez González, S.1
Hernández, A.I.2
Varela, C.3
Rodriguez-Aristegui, S.4
Alvarez, R.M.5
Garcia, A.B.6
Lorenzo, M.7
Rivero, V.8
Oyarzabal, J.9
Rabal, O.10
Bischoff, J.R.11
Albarrán, M.12
Cebriá, A.13
Alfonso, P.14
Link, W.15
Fominaya, J.16
Pastor, J.17
-
186
-
-
84860467003
-
Identification of ETP-46321, a Potent and Orally Bioavailable PI3K A, Inhibitor
-
Martinez González, S.; Hernández, A. I.; Varela, C.; Rodriguez-Aristegui, S.; Lorenzo, M.; Rodriguez, A.; Rivero, V.; Martin, J. I.; Saluste, C. G.; Ramos-Lima, F.; Cendon, E.; Cebrián, D.; Aguirre, E.; Gomez-Casero, E.; Albarrán, M.; Alfonso, P.; Garcia-Serelde, B.; Oyarzabal, J.; Rabal, O.; Mulero, F.; Gonzalez-Granda, T.; Link, W.; Fominaya, J.; Barbacid, M.; Bischoff, J. R.; Pizcueta, P.; Pastor, J. Identification of ETP-46321, a Potent and Orally Bioavailable PI3K A, Inhibitor Bioorg. Med. Chem. Lett. 2012, 22, 3460-3466
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 3460-3466
-
-
Martinez González, S.1
Hernández, A.I.2
Varela, C.3
Rodriguez-Aristegui, S.4
Lorenzo, M.5
Rodriguez, A.6
Rivero, V.7
Martin, J.I.8
Saluste, C.G.9
Ramos-Lima, F.10
Cendon, E.11
Cebrián, D.12
Aguirre, E.13
Gomez-Casero, E.14
Albarrán, M.15
Alfonso, P.16
Garcia-Serelde, B.17
Oyarzabal, J.18
Rabal, O.19
Mulero, F.20
Gonzalez-Granda, T.21
Link, W.22
Fominaya, J.23
Barbacid, M.24
Bischoff, J.R.25
Pizcueta, P.26
Pastor, J.27
more..
-
187
-
-
84864414528
-
Rapid Identification of ETP-46992, Orally Bioavailable PI3K Inhibitor, Selective versus mTOR
-
Martí;nez González, S.; Hernández, A. I.; Varela, C.; Lorenzo, M.; Ramos-Lima, F.; Cendó;n, E.; Cebrián, D.; Aguirre, E.; Gomez-Casero, E.; Albarrán, M. I.; Alfonso, P.; Garcí;a-Serelde, B.; Mateos, G.; Oyarzabal, J.; Rabal, O.; Mulero, F.; Gonzalez-Granda, T.; Link, W.; Fominaya, J.; Barbacid, M.; Bischoff, J. R.; Pizcueta, P.; Blanco-Aparicio, C.; Pastor, J. Rapid Identification of ETP-46992, Orally Bioavailable PI3K Inhibitor, Selective versus mTOR Bioorg. Med. Chem. Lett. 2012, 22, 5208-5214
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 5208-5214
-
-
Martinez González, S.1
Hernández, A.I.2
Varela, C.3
Lorenzo, M.4
Ramos-Lima, F.5
-
188
-
-
84873832557
-
Biological Characterization of ETP-46321 a Selective and Efficacious Inhibitor of Phosphoinositide-3-Kinases
-
Granda, T. G.; Cebrián, D.; Martí;nez, S.; Anguita, P. V.; Ló;pez, E. C.; Link, W.; Merino, T.; Pastor, J.; Serelde, B. G.; Peregrina, S.; Palacios, I.; Albarran, M. I.; Cebriá, A.; Lorenzo, M.; Alonso, P.; Fominaya, J.; Ló;pez, A. R.; Bischoff, J. R. Biological Characterization of ETP-46321 a Selective and Efficacious Inhibitor of Phosphoinositide-3-Kinases Invest. New Drugs 2013, 31, 66-76
-
(2013)
Invest. New Drugs
, vol.31
, pp. 66-76
-
-
Granda, T.G.1
Cebrián, D.2
Martí3
Nez, S.4
Anguita, P.V.5
Ló6
Pez, E.C.7
Link, W.8
Merino, T.9
Pastor, J.10
Serelde, B.G.11
Peregrina, S.12
Palacios, I.13
Albarran, M.I.14
Cebriá, A.15
Lorenzo, M.16
Alonso, P.17
Fominaya, J.18
Ló19
Pez, A.R.20
Bischoff, J.R.21
more..
-
189
-
-
72249111293
-
Novel Imidazolopyrimidines as Dual PI3-Kinase/mTOR Inhibitors
-
Venkatesan, A. M.; Dehnhardt, C. M.; Chen, Z.; Santos, E. D.; Dos Santos, O.; Bursavich, M.; Gilbert, A. M.; Ellingboe, J. W.; Ayral-Kaloustian, S.; Khafizova, G.; Brooijmans, N.; Mallon, R.; Hollander, I.; Feldberg, L.; Lucas, J.; Yu, K.; Gibbons, J.; Abraham, R.; Mansour, T. S. Novel Imidazolopyrimidines as Dual PI3-Kinase/mTOR Inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 653-656
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 653-656
-
-
Venkatesan, A.M.1
Dehnhardt, C.M.2
Chen, Z.3
Santos, E.D.4
Dos Santos, O.5
Bursavich, M.6
Gilbert, A.M.7
Ellingboe, J.W.8
Ayral-Kaloustian, S.9
Khafizova, G.10
Brooijmans, N.11
Mallon, R.12
Hollander, I.13
Feldberg, L.14
Lucas, J.15
Yu, K.16
Gibbons, J.17
Abraham, R.18
Mansour, T.S.19
-
190
-
-
77249098372
-
Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402
-
Dehnhardt, C. M.; Venkatesan, A. M.; Delos Santos, E.; Chen, Z.; Santos, O.; Ayral-Kaloustian, S.; Brooijmans, N.; Mallon, R.; Hollander, I.; Feldberg, L.; Lucas, J.; Chaudhary, I.; Yu, K.; Gibbons, J.; Abraham, R.; Mansour, T. S. Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402 J. Med. Chem. 2010, 53, 798-810
-
(2010)
J. Med. Chem.
, vol.53
, pp. 798-810
-
-
Dehnhardt, C.M.1
Venkatesan, A.M.2
Delos Santos, E.3
Chen, Z.4
Santos, O.5
Ayral-Kaloustian, S.6
Brooijmans, N.7
Mallon, R.8
Hollander, I.9
Feldberg, L.10
Lucas, J.11
Chaudhary, I.12
Yu, K.13
Gibbons, J.14
Abraham, R.15
Mansour, T.S.16
-
191
-
-
69049087738
-
ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines
-
Zask, A.; Verheijen, J. C.; Curran, K.; Kaplan, J.; Richard, D. J.; Nowak, P.; Malwitz, D. J.; Brooijmans, N.; Bard, J.; Svenson, K.; Lucas, J.; Toral-Barza, L.; Zhang, W.-G.; Hollander, I.; Gibbons, J. J.; Abraham, R. T.; Ayral-Kaloustian, S.; Mansour, T. S.; Yu, K. ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines J. Med. Chem. 2009, 52, 5013-5016
-
(2009)
J. Med. Chem.
, vol.52
, pp. 5013-5016
-
-
Zask, A.1
Verheijen, J.C.2
Curran, K.3
Kaplan, J.4
Richard, D.J.5
Nowak, P.6
Malwitz, D.J.7
Brooijmans, N.8
Bard, J.9
Svenson, K.10
Lucas, J.11
Toral-Barza, L.12
Zhang, W.-G.13
Hollander, I.14
Gibbons, J.J.15
Abraham, R.T.16
Ayral-Kaloustian, S.17
Mansour, T.S.18
Yu, K.19
-
192
-
-
77950810322
-
Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
-
Mallon, R.; Hollander, I.; Feldberg, L.; Lucas, J.; Soloveva, V.; Venkatesan, A.; Dehnhardt, C.; Delos Santos, E.; Chen, Z.; Dos Santos, O.; Ayral-Kaloustian, S.; Gibbons, J. Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor Mol. Cancer Ther. 2010, 9, 976-984
-
(2010)
Mol. Cancer Ther.
, vol.9
, pp. 976-984
-
-
Mallon, R.1
Hollander, I.2
Feldberg, L.3
Lucas, J.4
Soloveva, V.5
Venkatesan, A.6
Dehnhardt, C.7
Delos Santos, E.8
Chen, Z.9
Dos Santos, O.10
Ayral-Kaloustian, S.11
Gibbons, J.12
-
193
-
-
77951096315
-
Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors
-
Chen, Z.; Venkatesan, A. M.; Dehnhardt, C. M.; Ayral-Kaloustian, S.; Brooijmans, N.; Mallon, R.; Feldberg, L.; Hollander, I.; Lucas, J.; Yu, K.; Kong, F.; Mansour, T. S. Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors J. Med. Chem. 2010, 53, 3169-3182
-
(2010)
J. Med. Chem.
, vol.53
, pp. 3169-3182
-
-
Chen, Z.1
Venkatesan, A.M.2
Dehnhardt, C.M.3
Ayral-Kaloustian, S.4
Brooijmans, N.5
Mallon, R.6
Feldberg, L.7
Hollander, I.8
Lucas, J.9
Yu, K.10
Kong, F.11
Mansour, T.S.12
-
194
-
-
0033661820
-
Synthesis and Antitumor Activity of Benzimidazolyl-1,3,5-triazine and Benzimidazolylpyrimidine Derivatives
-
Matsuno, T.; Karo, M.; Sasahara, H.; Watanabe, T.; Inaba, M.; Takahashi, M.; Yaguchi, S. I.; Yoshioka, K.; Sakato, M.; Kawashima, S. Synthesis and Antitumor Activity of Benzimidazolyl-1,3,5-triazine and Benzimidazolylpyrimidine Derivatives Chem. Pharm. Bull. 2000, 48, 1778-1781
-
(2000)
Chem. Pharm. Bull.
, vol.48
, pp. 1778-1781
-
-
Matsuno, T.1
Karo, M.2
Sasahara, H.3
Watanabe, T.4
Inaba, M.5
Takahashi, M.6
Yaguchi, S.I.7
Yoshioka, K.8
Sakato, M.9
Kawashima, S.10
-
195
-
-
33646447708
-
Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor
-
Yaguchi, S.; Fukui, Y.; Koshimizu, I.; Yoshimi, H.; Matsuno, T.; Gouda, H.; Hirono, S.; Yamazaki, K.; Yamori, T. Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor J. Natl. Cancer Inst. 2006, 98, 545-556
-
(2006)
J. Natl. Cancer Inst.
, vol.98
, pp. 545-556
-
-
Yaguchi, S.1
Fukui, Y.2
Koshimizu, I.3
Yoshimi, H.4
Matsuno, T.5
Gouda, H.6
Hirono, S.7
Yamazaki, K.8
Yamori, T.9
-
196
-
-
34548189038
-
ZSTK474 Is an ATP-Competitive Inhibitor of Class i Phosphatidylinositol 3 Kinase Isoforms
-
Kong, D.; Yamori, T. ZSTK474 Is an ATP-Competitive Inhibitor of Class I Phosphatidylinositol 3 Kinase Isoforms Cancer Sci. 2007, 98, 1638-1642
-
(2007)
Cancer Sci.
, vol.98
, pp. 1638-1642
-
-
Kong, D.1
Yamori, T.2
-
197
-
-
58149294243
-
Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase
-
Kong, D.; Yaguchi, S.; Yamori, T. Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase Biol. Pharm. Bull. 2009, 32, 297-300
-
(2009)
Biol. Pharm. Bull.
, vol.32
, pp. 297-300
-
-
Kong, D.1
Yaguchi, S.2
Yamori, T.3
-
198
-
-
75349106113
-
The p110 Delta Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors
-
Berndt, A.; Miller, S.; Williams, O.; Le, D. D.; Houseman, B. T.; Pacold, J. I.; Gorrec, F.; Hon, W.-C.; Liu, Y.; Rommel, C.; Gaillard, P.; Rückle, T.; Schwarz, M. K.; Shokat, K. M.; Shaw, J. P.; Williams, R. L. The p110 Delta Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors Nat. Chem. Biol. 2010, 6, 117-124
-
(2010)
Nat. Chem. Biol.
, vol.6
, pp. 117-124
-
-
Berndt, A.1
Miller, S.2
Williams, O.3
Le, D.D.4
Houseman, B.T.5
Pacold, J.I.6
Gorrec, F.7
Hon, W.-C.8
Liu, Y.9
Rommel, C.10
Gaillard, P.11
Rückle, T.12
Schwarz, M.K.13
Shokat, K.M.14
Shaw, J.P.15
Williams, R.L.16
-
199
-
-
61349194402
-
Antiangiogenic Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor
-
Kong, D.; Okamura, M.; Yoshimi, H.; Yamori, T. Antiangiogenic Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor Eur. J. Cancer 2009, 45, 857-865
-
(2009)
Eur. J. Cancer
, vol.45
, pp. 857-865
-
-
Kong, D.1
Okamura, M.2
Yoshimi, H.3
Yamori, T.4
-
200
-
-
80054952210
-
Synthesis and Biological Evaluation of Novel Analogues of the Pan Class i Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-Triazin-2-yl]-1 H -benzimidazole (ZSTK474)
-
Rewcastle, G. W.; Gamage, S. A.; Flanagan, J. U.; Frederick, R.; Denny, W. A.; Baguley, B. C.; Kestell, P.; Singh, R.; Kendall, J. D.; Marshall, E. S.; Lill, C. L.; Lee, W.-J.; Kolekar, S.; Buchanan, C. M.; Jamieson, S. M. F.; Shepherd, P. R. Synthesis and Biological Evaluation of Novel Analogues of the Pan Class I Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-Triazin-2-yl]-1 H -benzimidazole (ZSTK474) J. Med. Chem. 2011, 54, 7105-7126
-
(2011)
J. Med. Chem.
, vol.54
, pp. 7105-7126
-
-
Rewcastle, G.W.1
Gamage, S.A.2
Flanagan, J.U.3
Frederick, R.4
Denny, W.A.5
Baguley, B.C.6
Kestell, P.7
Singh, R.8
Kendall, J.D.9
Marshall, E.S.10
Lill, C.L.11
Lee, W.-J.12
Kolekar, S.13
Buchanan, C.M.14
Jamieson, S.M.F.15
Shepherd, P.R.16
-
201
-
-
84872349849
-
Regioselective Synthesis of 5- and 6-Methoxybenzimidazole-1,3,5-triazines as Inhibitors of Phosphoinositide 3-Kinase
-
Miller, M. S.; Pinson, J.-A.; Zheng, Z.; Jennings, I. G.; Thompson, P. E. Regioselective Synthesis of 5- and 6-Methoxybenzimidazole-1,3,5-triazines as Inhibitors of Phosphoinositide 3-Kinase Bioorg. Med. Chem. Lett. 2013, 23, 802-805
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, pp. 802-805
-
-
Miller, M.S.1
Pinson, J.-A.2
Zheng, Z.3
Jennings, I.G.4
Thompson, P.E.5
-
202
-
-
78651509350
-
Preparation and Evaluation of Trisubstituted Pyrimidines as Phosphatidylinositol 3-Kinase Inhibitors. 3-Hydroxyphenol Analogues and Bioisosteric Replacements
-
Large, J. M.; Torr, J. E.; Raynaud, F. I.; Clarke, P. A.; Hayes, A.; Stefano, F. di; Urban, F.; Shuttleworth, S. J.; Saghir, N.; Sheldrake, P.; Workman, P.; McDonald, E. Preparation and Evaluation of Trisubstituted Pyrimidines as Phosphatidylinositol 3-Kinase Inhibitors. 3-Hydroxyphenol Analogues and Bioisosteric Replacements Bioorg. Med. Chem. 2011, 19, 836-851
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 836-851
-
-
Large, J.M.1
Torr, J.E.2
Raynaud, F.I.3
Clarke, P.A.4
Hayes, A.5
Stefano, F.D.6
Urban, F.7
Shuttleworth, S.J.8
Saghir, N.9
Sheldrake, P.10
Workman, P.11
McDonald, E.12
-
203
-
-
77956255150
-
WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant
-
Li, T.; Wang, J.; Wang, X.; Yang, N.; Chen, S.-M.; Tong, L.-J.; Yang, C.-H.; Meng, L.-H.; Ding, J. WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant J. Pharmacol. Exp. Ther. 2010, 334, 830-838
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.334
, pp. 830-838
-
-
Li, T.1
Wang, J.2
Wang, X.3
Yang, N.4
Chen, S.-M.5
Tong, L.-J.6
Yang, C.-H.7
Meng, L.-H.8
Ding, J.9
-
204
-
-
78149283201
-
Identification and Structure-Activity Relationship of 2-Morpholino 6-(3-hydroxyphenyl) Pyrimidines, a Class of Potent and Selective PI3 Kinase Inhibitors
-
Pecchi, S.; Renhowe, P. A.; Taylor, C.; Kaufman, S.; Merritt, H.; Wiesmann, M.; Shoemaker, K. R.; Knapp, M. S.; Ornelas, E.; Hendrickson, T. F.; Fantl, W.; Voliva, C. F. Identification and Structure-Activity Relationship of 2-Morpholino 6-(3-hydroxyphenyl) Pyrimidines, a Class of Potent and Selective PI3 Kinase Inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 6895-6898
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 6895-6898
-
-
Pecchi, S.1
Renhowe, P.A.2
Taylor, C.3
Kaufman, S.4
Merritt, H.5
Wiesmann, M.6
Shoemaker, K.R.7
Knapp, M.S.8
Ornelas, E.9
Hendrickson, T.F.10
Fantl, W.11
Voliva, C.F.12
-
205
-
-
78651479722
-
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-Kinase Inhibitors
-
Burger, M. T.; Knapp, M.; Wagman, A.; Ni, Z.-J.; Hendrickson, T.; Atallah, G.; Zhang, Y.; Frazier, K.; Verhagen, J.; Pfister, K.; Ng, S.; Smith, A.; Bartulis, S.; Merrit, H.; Weismann, M.; Xin, X.; Haznedar, J.; Voliva, C. F.; Iwanowicz, E.; Pecchi, S. Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-Kinase Inhibitors ACS Med. Chem. Lett. 2011, 2, 34-38
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 34-38
-
-
Burger, M.T.1
Knapp, M.2
Wagman, A.3
Ni, Z.-J.4
Hendrickson, T.5
Atallah, G.6
Zhang, Y.7
Frazier, K.8
Verhagen, J.9
Pfister, K.10
Ng, S.11
Smith, A.12
Bartulis, S.13
Merrit, H.14
Weismann, M.15
Xin, X.16
Haznedar, J.17
Voliva, C.F.18
Iwanowicz, E.19
Pecchi, S.20
more..
-
206
-
-
80054737055
-
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class i PI3 Kinase Inhibitor for Treating Cancer
-
Burger, M. T.; Pecchi, S.; Wagman, A.; Ni, Z.-J.; Knapp, M.; Hendrickson, T.; Atallah, G.; Pfister, K.; Zhang, Y.; Bartulis, S.; Frazier, K.; Ng, S.; Smith, A.; Verhagen, J.; Haznedar, J.; Huh, K.; Iwanowicz, E.; Xin, X.; Menezes, D.; Merritt, H.; Lee, I.; Wiesmann, M.; Kaufman, S.; Crawford, K.; Chin, M.; Bussiere, D.; Shoemaker, K.; Zaror, I.; Maira, S.-M.; Voliva, C. F. Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer ACS Med. Chem. Lett. 2011, 2, 774-779
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 774-779
-
-
Burger, M.T.1
Pecchi, S.2
Wagman, A.3
Ni, Z.-J.4
Knapp, M.5
Hendrickson, T.6
Atallah, G.7
Pfister, K.8
Zhang, Y.9
Bartulis, S.10
Frazier, K.11
Ng, S.12
Smith, A.13
Verhagen, J.14
Haznedar, J.15
Huh, K.16
Iwanowicz, E.17
Xin, X.18
Menezes, D.19
Merritt, H.20
Lee, I.21
Wiesmann, M.22
Kaufman, S.23
Crawford, K.24
Chin, M.25
Bussiere, D.26
Shoemaker, K.27
Zaror, I.28
Maira, S.-M.29
Voliva, C.F.30
more..
-
207
-
-
84856826293
-
Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class i PI3-Kinase Inhibitor
-
Maira, S.-M.; Pecchi, S.; Huang, A.; Burger, M.; Knapp, M.; Sterker, D.; Schnell, C.; Guthy, D.; Nagel, T.; Wiesmann, M.; Brachmann, S.; Fritsch, C.; Dorsch, M.; Chene, P.; Shoemaker, K.; De Pover, A.; Menezes, D.; Martiny-Baron, G.; Fabbro, D.; Wilson, C. J.; Schlegel, R.; Hofmann, F.; Garcí;a-Echeverrí;a, C.; Sellers, W. R.; Voliva, C. F. Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor Mol. Cancer Ther. 2012, 11, 317-328
-
(2012)
Mol. Cancer Ther.
, vol.11
, pp. 317-328
-
-
Maira, S.-M.1
Pecchi, S.2
Huang, A.3
Burger, M.4
Knapp, M.5
Sterker, D.6
Schnell, C.7
Guthy, D.8
-
208
-
-
84856071447
-
Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class i PI3K Inhibitor, in Patients with Advanced Solid Tumors
-
Bendell, J. C.; Rodon, J.; Burris, H. A.; de Jonge, M.; Verweij, J.; Birle, D.; Demanse, D.; De Buck, S. S.; Ru, Q. C.; Peters, M.; Goldbrunner, M.; Baselga, J. Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors J. Clin. Oncol. 2012, 30, 282-290
-
(2012)
J. Clin. Oncol.
, vol.30
, pp. 282-290
-
-
Bendell, J.C.1
Rodon, J.2
Burris, H.A.3
De Jonge, M.4
Verweij, J.5
Birle, D.6
Demanse, D.7
De Buck, S.S.8
Ru, Q.C.9
Peters, M.10
Goldbrunner, M.11
Baselga, J.12
-
209
-
-
77949785193
-
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5-Triphosphate Competitive Phosphatidylinositol-3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor
-
Venkatesan, A. M.; Dehnhardt, C. M.; Delos Santos, E.; Chen, Z.; Dos Santos, O.; Ayral-Kaloustian, S.; Khafizova, G.; Brooijmans, N.; Mallon, R.; Hollander, I.; Feldberg, L.; Lucas, J.; Yu, K.; Gibbons, J.; Abraham, R. T.; Chaudhary, I.; Mansour, T. S. Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5-Triphosphate Competitive Phosphatidylinositol-3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor J. Med. Chem. 2010, 53, 2636-2645
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2636-2645
-
-
Venkatesan, A.M.1
Dehnhardt, C.M.2
Delos Santos, E.3
Chen, Z.4
Dos Santos, O.5
Ayral-Kaloustian, S.6
Khafizova, G.7
Brooijmans, N.8
Mallon, R.9
Hollander, I.10
Feldberg, L.11
Lucas, J.12
Yu, K.13
Gibbons, J.14
Abraham, R.T.15
Chaudhary, I.16
Mansour, T.S.17
-
210
-
-
79955996030
-
Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor
-
Mallon, R.; Feldberg, L. R.; Lucas, J.; Chaudhary, I.; Dehnhardt, C.; Santos, E. D.; Chen, Z.; dos Santos, O.; Ayral-Kaloustian, S.; Venkatesan, A.; Hollander, I. Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor Clin. Cancer Res. 2011, 17, 3193-3203
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 3193-3203
-
-
Mallon, R.1
Feldberg, L.R.2
Lucas, J.3
Chaudhary, I.4
Dehnhardt, C.5
Santos, E.D.6
Chen, Z.7
Dos Santos, O.8
Ayral-Kaloustian, S.9
Venkatesan, A.10
Hollander, I.11
-
211
-
-
77957549846
-
PKI-179: An Orally Efficacious Dual Phosphatidylinositol-3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Inhibitor
-
Venkatesan, A. M.; Chen, Z.; dos Santos, O.; Dehnhardt, C.; Santos, E. D.; Ayral-Kaloustian, S.; Mallon, R.; Hollander, I.; Feldberg, L.; Lucas, J.; Yu, K.; Chaudhary, I.; Mansour, T. S. PKI-179: An Orally Efficacious Dual Phosphatidylinositol-3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Inhibitor Bioorg. Med. Chem. Lett. 2010, 20, 5869-5873
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 5869-5873
-
-
Venkatesan, A.M.1
Chen, Z.2
Dos Santos, O.3
Dehnhardt, C.4
Santos, E.D.5
Ayral-Kaloustian, S.6
Mallon, R.7
Hollander, I.8
Feldberg, L.9
Lucas, J.10
Yu, K.11
Chaudhary, I.12
Mansour, T.S.13
-
212
-
-
79960925038
-
Identification of 2-Oxatriazines as Highly Potent Pan-PI3K/mTOR Dual Inhibitors
-
Dehnhardt, C. M.; Venkatesan, A. M.; Chen, Z.; Delos-Santos, E.; Ayral-Kaloustian, S.; Brooijmans, N.; Yu, K.; Hollander, I.; Feldberg, L.; Lucas, J.; Mallon, R. Identification of 2-Oxatriazines as Highly Potent Pan-PI3K/mTOR Dual Inhibitors Bioorg. Med. Chem. Lett. 2011, 21, 4773-4778
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 4773-4778
-
-
Dehnhardt, C.M.1
Venkatesan, A.M.2
Chen, Z.3
Delos-Santos, E.4
Ayral-Kaloustian, S.5
Brooijmans, N.6
Yu, K.7
Hollander, I.8
Feldberg, L.9
Lucas, J.10
Mallon, R.11
-
213
-
-
79952359845
-
Discovery and Biological Activity of a Novel Class i PI3K Inhibitor, CH5132799
-
Ohwada, J.; Ebiike, H.; Kawada, H.; Tsukazaki, M.; Nakamura, M.; Miyazaki, T.; Morikami, K.; Yoshinari, K.; Yoshida, M.; Kondoh, O.; Kuramoto, S.; Ogawa, K.; Aoki, Y.; Shimma, N. Discovery and Biological Activity of a Novel Class I PI3K Inhibitor, CH5132799 Bioorg. Med. Chem. Lett. 2011, 21, 1767-1772
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 1767-1772
-
-
Ohwada, J.1
Ebiike, H.2
Kawada, H.3
Tsukazaki, M.4
Nakamura, M.5
Miyazaki, T.6
Morikami, K.7
Yoshinari, K.8
Yoshida, M.9
Kondoh, O.10
Kuramoto, S.11
Ogawa, K.12
Aoki, Y.13
Shimma, N.14
-
214
-
-
84874041832
-
VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer
-
Hart, S.; Novotny-Diermayr, V.; Goh, K. C.; Williams, M.; Tan, Y. C.; Ong, L. C.; Cheong, A.; Ng, B. K.; Amalini, C.; Madan, B.; Nagaraj, H.; Jayaraman, R.; Pasha, K. M.; Ethirajulu, K.; Chng, W. J.; Mustafa, N.; Goh, B. C.; Benes, C.; McDermott, U.; Garnett, M.; Dymock, B.; Wood, J. M. VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer Mol. Cancer Ther. 2013, 12, 151-161
-
(2013)
Mol. Cancer Ther.
, vol.12
, pp. 151-161
-
-
Hart, S.1
Novotny-Diermayr, V.2
Goh, K.C.3
Williams, M.4
Tan, Y.C.5
Ong, L.C.6
Cheong, A.7
Ng, B.K.8
Amalini, C.9
Madan, B.10
Nagaraj, H.11
Jayaraman, R.12
Pasha, K.M.13
Ethirajulu, K.14
Chng, W.J.15
Mustafa, N.16
Goh, B.C.17
Benes, C.18
McDermott, U.19
Garnett, M.20
Dymock, B.21
Wood, J.M.22
more..
-
215
-
-
84866331531
-
Discovery and in Vivo Evaluation of Dual PI3KInhibitors
-
Gonzalez-Lopez de Turiso, F.; Shin, Y.; Brown, M.; Cardozo, M.; Chen, Y.; Fong, D.; Hao, X.; He, X.; Henne, K.; Hu, Y.-L.; Johnson, M. G.; Kohn, T.; Lohman, J.; McBride, H. J.; McGee, L. R.; Medina, J. C.; Metz, D.; Miner, K.; Mohn, D.; Pattaropong, V.; Seganish, J.; Simard, J. L.; Wannberg, S.; Whittington, D. A.; Yu, G.; Cushing, T. D. Discovery and in Vivo Evaluation of Dual PI3KInhibitors J. Med. Chem. 2012, 55, 7667-7685
-
(2012)
J. Med. Chem.
, vol.55
, pp. 7667-7685
-
-
Gonzalez-Lopez De Turiso, F.1
Shin, Y.2
Brown, M.3
Cardozo, M.4
Chen, Y.5
Fong, D.6
Hao, X.7
He, X.8
Henne, K.9
Hu, Y.-L.10
Johnson, M.G.11
Kohn, T.12
Lohman, J.13
McBride, H.J.14
McGee, L.R.15
Medina, J.C.16
Metz, D.17
Miner, K.18
Mohn, D.19
Pattaropong, V.20
Seganish, J.21
Simard, J.L.22
Wannberg, S.23
Whittington, D.A.24
Yu, G.25
Cushing, T.D.26
more..
-
216
-
-
84920992133
-
-
WO2006114606.
-
Alexander, R. P.; Aujla, P.; Batchelor, M. J.; Brookings, D. C.; Buckley, G. M.; Crepy, K. V. L.; Kulisa, C. L.; Turner, J. P. Fused Thiazole Derivatives as Kinase Inhibitors. WO2006114606, 2006.
-
(2006)
Fused Thiazole Derivatives As Kinase Inhibitors
-
-
Alexander, R.P.1
Aujla, P.2
Batchelor, M.J.3
Brookings, D.C.4
Buckley, G.M.5
Crepy, K.V.L.6
Kulisa, C.L.7
Turner, J.P.8
-
217
-
-
47749100391
-
4-(1,3-Thiazol-2-yl)morpholine Derivatives as Inhibitors of Phosphoinositide 3-Kinase
-
Alexander, R.; Balasundaram, A.; Batchelor, M.; Brookings, D.; Crépy, K.; Crabbe, T.; Deltent, M.-F.; Driessens, F.; Gill, A.; Harris, S.; Hutchinson, G.; Kulisa, C.; Merriman, M.; Mistry, P.; Parton, T.; Turner, J.; Whitcombe, I.; Wright, S. 4-(1,3-Thiazol-2-yl)morpholine Derivatives as Inhibitors of Phosphoinositide 3-Kinase Bioorg. Med. Chem. Lett. 2008, 18, 4316-4320
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4316-4320
-
-
Alexander, R.1
Balasundaram, A.2
Batchelor, M.3
Brookings, D.4
Crépy, K.5
Crabbe, T.6
Deltent, M.-F.7
Driessens, F.8
Gill, A.9
Harris, S.10
Hutchinson, G.11
Kulisa, C.12
Merriman, M.13
Mistry, P.14
Parton, T.15
Turner, J.16
Whitcombe, I.17
Wright, S.18
-
218
-
-
48849100158
-
Achieving Multi-Isoform PI3K Inhibition in a Series of Substituted 3,4-Dihydro-2 H -benzo[1,4]oxazines
-
Perry, B.; Alexander, R.; Bennett, G.; Buckley, G.; Ceska, T.; Crabbe, T.; Dale, V.; Gowers, L.; Horsley, H.; James, L.; Jenkins, K.; Crépy, K.; Kulisa, C.; Lightfoot, H.; Lock, C.; Mack, S.; Morgan, T.; Nicolas, A.-L.; Pitt, W.; Sabin, V.; Wright, S. Achieving Multi-Isoform PI3K Inhibition in a Series of Substituted 3,4-Dihydro-2 H -benzo[1,4]oxazines Bioorg. Med. Chem. Lett. 2008, 18, 4700-4704
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4700-4704
-
-
Perry, B.1
Alexander, R.2
Bennett, G.3
Buckley, G.4
Ceska, T.5
Crabbe, T.6
Dale, V.7
Gowers, L.8
Horsley, H.9
James, L.10
Jenkins, K.11
Crépy, K.12
Kulisa, C.13
Lightfoot, H.14
Lock, C.15
Mack, S.16
Morgan, T.17
Nicolas, A.-L.18
Pitt, W.19
Sabin, V.20
Wright, S.21
more..
-
219
-
-
52249099895
-
Optimization of a Series of Multi-Isoform PI3 Kinase Inhibitors
-
Perry, B.; Beevers, R.; Bennett, G.; Buckley, G.; Crabbe, T.; Gowers, L.; James, L.; Jenkins, K.; Lock, C.; Sabin, V.; Wright, S. Optimization of a Series of Multi-Isoform PI3 Kinase Inhibitors Bioorg. Med. Chem. Lett. 2008, 18, 5299-5302
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 5299-5302
-
-
Perry, B.1
Beevers, R.2
Bennett, G.3
Buckley, G.4
Crabbe, T.5
Gowers, L.6
James, L.7
Jenkins, K.8
Lock, C.9
Sabin, V.10
Wright, S.11
-
220
-
-
80955128586
-
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity
-
Liu, K. K.-C.; Zhu, J.; Smith, G. L.; Yin, M.-J.; Bailey, S.; Chen, J. H.; Hu, Q.; Huang, Q.; Li, C.; Li, Q. J.; Marx, M. A.; Paderes, G.; Richardson, P. F.; Sach, N. W.; Walls, M.; Wells, P. A.; Zou, A. Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity ACS Med. Chem. Lett. 2011, 2, 809-813
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 809-813
-
-
Liu, K.K.-C.1
Zhu, J.2
Smith, G.L.3
Yin, M.-J.4
Bailey, S.5
Chen, J.H.6
Hu, Q.7
Huang, Q.8
Li, C.9
Li, Q.J.10
Marx, M.A.11
Paderes, G.12
Richardson, P.F.13
Sach, N.W.14
Walls, M.15
Wells, P.A.16
Zou, A.17
-
221
-
-
79960192285
-
Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure-Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
-
Nishimura, N.; Siegmund, A.; Liu, L.; Yang, K.; Bryan, M. C.; Andrews, K. L.; Bo, Y.; Booker, S. K.; Caenepeel, S.; Freeman, D.; Liao, H.; McCarter, J.; Mullady, E. L.; San Miguel, T.; Subramanian, R.; Tamayo, N.; Wang, L.; Whittington, D. A.; Zalameda, L.; Zhang, N.; Hughes, P. E.; Norman, M. H. Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure-Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives J. Med. Chem. 2011, 54, 4735-4751
-
(2011)
J. Med. Chem.
, vol.54
, pp. 4735-4751
-
-
Nishimura, N.1
Siegmund, A.2
Liu, L.3
Yang, K.4
Bryan, M.C.5
Andrews, K.L.6
Bo, Y.7
Booker, S.K.8
Caenepeel, S.9
Freeman, D.10
Liao, H.11
McCarter, J.12
Mullady, E.L.13
San Miguel, T.14
Subramanian, R.15
Tamayo, N.16
Wang, L.17
Whittington, D.A.18
Zalameda, L.19
Zhang, N.20
Hughes, P.E.21
Norman, M.H.22
more..
-
222
-
-
77954629282
-
-
WO2009085230A1.
-
Booker, S.; Kim, T. S.; Liao, H.; Liu, L.; Norman, M. H.; Peterson, E. A.; Stec, M.; Tamayo, N. A. Inhibitors of PI3 Kinase. WO2009085230A1, 2009.
-
(2009)
Inhibitors of PI3 Kinase
-
-
Booker, S.1
Kim, T.S.2
Liao, H.3
Liu, L.4
Norman, M.H.5
Peterson, E.A.6
Stec, M.7
Tamayo, N.A.8
-
223
-
-
79952792112
-
Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
-
DAngelo, N. D.; Kim, T.-S.; Andrews, K.; Booker, S. K.; Caenepeel, S.; Chen, K.; DAmico, D.; Freeman, D.; Jiang, J.; Liu, L.; McCarter, J. D.; San Miguel, T.; Mullady, E. L.; Schrag, M.; Subramanian, R.; Tang, J.; Wahl, R. C.; Wang, L.; Whittington, D. A.; Wu, T.; Xi, N.; Xu, Y.; Yakowec, P.; Yang, K.; Zalameda, L. P.; Zhang, N.; Hughes, P.; Norman, M. H. Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors J. Med. Chem. 2011, 54, 1789-1811
-
(2011)
J. Med. Chem.
, vol.54
, pp. 1789-1811
-
-
Dangelo, N.D.1
Kim, T.-S.2
Andrews, K.3
Booker, S.K.4
Caenepeel, S.5
Chen, K.6
Damico, D.7
Freeman, D.8
Jiang, J.9
Liu, L.10
McCarter, J.D.11
San Miguel, T.12
Mullady, E.L.13
Schrag, M.14
Subramanian, R.15
Tang, J.16
Wahl, R.C.17
Wang, L.18
Whittington, D.A.19
Wu, T.20
Xi, N.21
Xu, Y.22
Yakowec, P.23
Yang, K.24
Zalameda, L.P.25
Zhang, N.26
Hughes, P.27
Norman, M.H.28
more..
-
224
-
-
23844438209
-
Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition
-
Sun, S.-Y.; Rosenberg, L. M.; Wang, X.; Zhou, Z.; Yue, P.; Fu, H.; Khuri, F. R. Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition Cancer Res. 2005, 65, 7052-7058
-
(2005)
Cancer Res.
, vol.65
, pp. 7052-7058
-
-
Sun, S.-Y.1
Rosenberg, L.M.2
Wang, X.3
Zhou, Z.4
Yue, P.5
Fu, H.6
Khuri, F.R.7
-
225
-
-
79957983577
-
Targeting the PI3K/Akt/mTOR Pathway-Beyond Rapalogs
-
Markman, B.; Dienstmann, R.; Tabernero, J. Targeting the PI3K/Akt/mTOR Pathway-Beyond Rapalogs Oncotarget 2010, 1, 530-543
-
(2010)
Oncotarget
, vol.1
, pp. 530-543
-
-
Markman, B.1
Dienstmann, R.2
Tabernero, J.3
-
226
-
-
80155142474
-
Rapamycin Passes the Torch: A New Generation of mTOR Inhibitors
-
Benjamin, D.; Colombi, M.; Moroni, C.; Hall, M. N. Rapamycin Passes the Torch: A New Generation of mTOR Inhibitors Nat. Rev. Drug Discovery 2011, 10, 868-880
-
(2011)
Nat. Rev. Drug Discovery
, vol.10
, pp. 868-880
-
-
Benjamin, D.1
Colombi, M.2
Moroni, C.3
Hall, M.N.4
-
227
-
-
70349256453
-
The Discovery and Optimisation of Pyrido[2,3- d ]pyrimidine-2,4-diamines as Potent and Selective Inhibitors of mTOR Kinase
-
Malagu, K.; Duggan, H.; Menear, K.; Hummersone, M.; Gomez, S.; Bailey, C.; Edwards, P.; Drzewiecki, J.; Leroux, F.; Quesada, M. J.; Hermann, G.; Maine, S.; Molyneaux, C.-A.; Le Gall, A.; Pullen, J.; Hickson, I.; Smith, L.; Maguire, S.; Martin, N.; Smith, G.; Pass, M. The Discovery and Optimisation of Pyrido[2,3- d ]pyrimidine-2,4-diamines as Potent and Selective Inhibitors of mTOR Kinase Bioorg. Med. Chem. Lett. 2009, 19, 5950-5953
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 5950-5953
-
-
Malagu, K.1
Duggan, H.2
Menear, K.3
Hummersone, M.4
Gomez, S.5
Bailey, C.6
Edwards, P.7
Drzewiecki, J.8
Leroux, F.9
Quesada, M.J.10
Hermann, G.11
Maine, S.12
Molyneaux, C.-A.13
Le Gall, A.14
Pullen, J.15
Hickson, I.16
Smith, L.17
Maguire, S.18
Martin, N.19
Smith, G.20
Pass, M.21
more..
-
228
-
-
67650312583
-
Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)
-
García-Martí;nez, J. M.; Moran, J.; Clarke, R. G.; Gray, A.; Cosulich, S. C.; Chresta, C. M.; Alessi, D. R. Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR) Biochem. J. 2009, 421, 29-42
-
(2009)
Biochem. J.
, vol.421
, pp. 29-42
-
-
García-Martí1
Nez, J.M.2
Moran, J.3
Clarke, R.G.4
Gray, A.5
Cosulich, S.C.6
Chresta, C.M.7
Alessi, D.R.8
-
229
-
-
84873731572
-
Optimization of Potent and Selective Dual mTORC1 and mTORC2 Inhibitors: The Discovery of AZD8055 and AZD2014
-
Pike, K. G.; Malagu, K.; Hummersone, M. G.; Menear, K. A.; Duggan, H. M. E.; Gomez, S.; Martin, N. M. B.; Ruston, L.; Pass, S. L.; Pass, M. Optimization of Potent and Selective Dual mTORC1 and mTORC2 Inhibitors: The Discovery of AZD8055 and AZD2014 Bioorg. Med. Chem. Lett. 2013, 23, 1212-1216
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, pp. 1212-1216
-
-
Pike, K.G.1
Malagu, K.2
Hummersone, M.G.3
Menear, K.A.4
Duggan, H.M.E.5
Gomez, S.6
Martin, N.M.B.7
Ruston, L.8
Pass, S.L.9
Pass, M.10
-
230
-
-
75149112670
-
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity
-
Chresta, C. M.; Davies, B. R.; Hickson, I.; Harding, T.; Cosulich, S.; Critchlow, S. E.; Vincent, J. P.; Ellston, R.; Jones, D.; Sini, P.; James, D.; Howard, Z.; Dudley, P.; Hughes, G.; Smith, L.; Maguire, S.; Hummersone, M.; Malagu, K.; Menear, K.; Jenkins, R.; Jacobsen, M.; Smith, G. C. M.; Guichard, S.; Pass, M. AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity Cancer Res. 2010, 70, 288-298
-
(2010)
Cancer Res.
, vol.70
, pp. 288-298
-
-
Chresta, C.M.1
Davies, B.R.2
Hickson, I.3
Harding, T.4
Cosulich, S.5
Critchlow, S.E.6
Vincent, J.P.7
Ellston, R.8
Jones, D.9
Sini, P.10
James, D.11
Howard, Z.12
Dudley, P.13
Hughes, G.14
Smith, L.15
Maguire, S.16
Hummersone, M.17
Malagu, K.18
Menear, K.19
Jenkins, R.20
Jacobsen, M.21
Smith, G.C.M.22
Guichard, S.23
Pass, M.24
more..
-
231
-
-
70949092751
-
Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase
-
Nowak, P.; Cole, D. C.; Brooijmans, N.; Bursavich, M. G.; Curran, K. J.; Ellingboe, J. W.; Gibbons, J. J.; Hollander, I.; Hu, Y.; Kaplan, J.; Malwitz, D. J.; Toral-Barza, L.; Verheijen, J. C.; Zask, A.; Zhang, W.-G.; Yu, K. Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase J. Med. Chem. 2009, 52, 7081-7089
-
(2009)
J. Med. Chem.
, vol.52
, pp. 7081-7089
-
-
Nowak, P.1
Cole, D.C.2
Brooijmans, N.3
Bursavich, M.G.4
Curran, K.J.5
Ellingboe, J.W.6
Gibbons, J.J.7
Hollander, I.8
Hu, Y.9
Kaplan, J.10
Malwitz, D.J.11
Toral-Barza, L.12
Verheijen, J.C.13
Zask, A.14
Zhang, W.-G.15
Yu, K.16
-
232
-
-
73249124369
-
Discovery of 4-Morpholino-6-aryl-1 H -pyrazolo[3,4- d ]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent
-
Verheijen, J. C.; Richard, D. J.; Curran, K.; Kaplan, J.; Lefever, M.; Nowak, P.; Malwitz, D. J.; Brooijmans, N.; Toral-Barza, L.; Zhang, W.-G.; Lucas, J.; Hollander, I.; Ayral-Kaloustian, S.; Mansour, T. S.; Yu, K.; Zask, A. Discovery of 4-Morpholino-6-aryl-1 H -pyrazolo[3,4- d ]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent J. Med. Chem. 2009, 52, 8010-8024
-
(2009)
J. Med. Chem.
, vol.52
, pp. 8010-8024
-
-
Verheijen, J.C.1
Richard, D.J.2
Curran, K.3
Kaplan, J.4
Lefever, M.5
Nowak, P.6
Malwitz, D.J.7
Brooijmans, N.8
Toral-Barza, L.9
Zhang, W.-G.10
Lucas, J.11
Hollander, I.12
Ayral-Kaloustian, S.13
Mansour, T.S.14
Yu, K.15
Zask, A.16
-
233
-
-
68049137608
-
Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
-
Yu, K.; Toral-Barza, L.; Shi, C.; Zhang, W.-G.; Lucas, J.; Shor, B.; Kim, J.; Verheijen, J.; Curran, K.; Malwitz, D. J.; Cole, D. C.; Ellingboe, J.; Ayral-Kaloustian, S.; Mansour, T. S.; Gibbons, J. J.; Abraham, R. T.; Nowak, P.; Zask, A. Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin Cancer Res. 2009, 69, 6232-6240
-
(2009)
Cancer Res.
, vol.69
, pp. 6232-6240
-
-
Yu, K.1
Toral-Barza, L.2
Shi, C.3
Zhang, W.-G.4
Lucas, J.5
Shor, B.6
Kim, J.7
Verheijen, J.8
Curran, K.9
Malwitz, D.J.10
Cole, D.C.11
Ellingboe, J.12
Ayral-Kaloustian, S.13
Mansour, T.S.14
Gibbons, J.J.15
Abraham, R.T.16
Nowak, P.17
Zask, A.18
-
234
-
-
77954639869
-
-
WO2009111547A1.
-
Venkatesan, A. M.; Chen, Z.; Dos Santos, O.; Brooijmans, N.; Gopalsamy, A. 7 H -Pyrrolo[2,3- h ]quinazoline Compounds, Their Use as mTOR Kinase and PI3 Kinase Inhibitors and Their Synthesis. WO2009111547A1, 2009.
-
(2009)
7 H -Pyrrolo[2,3- H ]Quinazoline Compounds, Their Use As MTOR Kinase and PI3 Kinase Inhibitors and Their Synthesis
-
-
Venkatesan, A.M.1
Chen, Z.2
Dos Santos, O.3
Brooijmans, N.4
Gopalsamy, A.5
-
235
-
-
84862779787
-
Inhibition of Tumor Cell Growth, Proliferation and Migration by X-387, a Novel Active-Site Inhibitor of mTOR
-
Chen, S.; Liu, J.; Wang, X.; Liang, C.; Ding, J.; Meng, L. Inhibition of Tumor Cell Growth, Proliferation and Migration by X-387, a Novel Active-Site Inhibitor of mTOR Biochem. Pharmacol. 2012, 83, 1183-1194
-
(2012)
Biochem. Pharmacol.
, vol.83
, pp. 1183-1194
-
-
Chen, S.1
Liu, J.2
Wang, X.3
Liang, C.4
Ding, J.5
Meng, L.6
-
236
-
-
70349199015
-
Identification and Optimisation of Novel and Selective Small Molecular Weight Kinase Inhibitors of mTOR
-
Menear, K. A.; Gomez, S.; Malagu, K.; Bailey, C.; Blackburn, K.; Cockcroft, X.-L.; Ewen, S.; Fundo, A.; Le Gall, A.; Hermann, G.; Sebastian, L.; Sunose, M.; Presnot, T.; Torode, E.; Hickson, I.; Martin, N. M. B.; Smith, G. C. M.; Pike, K. G. Identification and Optimisation of Novel and Selective Small Molecular Weight Kinase Inhibitors of mTOR Bioorg. Med. Chem. Lett. 2009, 19, 5898-5901
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 5898-5901
-
-
Menear, K.A.1
Gomez, S.2
Malagu, K.3
Bailey, C.4
Blackburn, K.5
Cockcroft, X.-L.6
Ewen, S.7
Fundo, A.8
Le Gall, A.9
Hermann, G.10
Sebastian, L.11
Sunose, M.12
Presnot, T.13
Torode, E.14
Hickson, I.15
Martin, N.M.B.16
Smith, G.C.M.17
Pike, K.G.18
-
237
-
-
84861570789
-
Sulfonyl-morpholino-pyrimidines: SAR and Development of a Novel Class of Selective mTOR Kinase Inhibitor
-
Finlay, M. R. V.; Buttar, D.; Critchlow, S. E.; Dishington, A. P.; Fillery, S. M.; Fisher, E.; Glossop, S. C.; Graham, M. A.; Johnson, T.; Lamont, G. M.; Mutton, S.; Perkins, P.; Pike, K. G.; Slater, A. M. Sulfonyl-morpholino-pyrimidines: SAR and Development of a Novel Class of Selective mTOR Kinase Inhibitor Bioorg. Med. Chem. Lett. 2012, 22, 4163-4168
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 4163-4168
-
-
Finlay, M.R.V.1
Buttar, D.2
Critchlow, S.E.3
Dishington, A.P.4
Fillery, S.M.5
Fisher, E.6
Glossop, S.C.7
Graham, M.A.8
Johnson, T.9
Lamont, G.M.10
Mutton, S.11
Perkins, P.12
Pike, K.G.13
Slater, A.M.14
-
238
-
-
84863984121
-
Conformationally-Restricted Cyclic Sulfones as Potent and Selective mTOR Kinase Inhibitors
-
Liu, K. K.-C.; Bailey, S.; Dinh, D. M.; Lam, H.; Li, C.; Wells, P. A.; Yin, M.-J.; Zou, A. Conformationally-Restricted Cyclic Sulfones as Potent and Selective mTOR Kinase Inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 5114-5117
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 5114-5117
-
-
Liu, K.K.-C.1
Bailey, S.2
Dinh, D.M.3
Lam, H.4
Li, C.5
Wells, P.A.6
Yin, M.-J.7
Zou, A.8
-
239
-
-
84871649701
-
Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity
-
Koehler, M. F. T.; Bergeron, P.; Blackwood, E.; Bowman, K. K.; Chen, Y.-H.; Deshmukh, G.; Ding, X.; Epler, J.; Lau, K.; Lee, L.; Liu, L.; Ly, C.; Malek, S.; Nonomiya, J.; Oeh, J.; Ortwine, D. F.; Sampath, D.; Sideris, S.; Trinh, L.; Truong, T.; Wu, J.; Pei, Z.; Lyssikatos, J. P. Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity J. Med. Chem. 2012, 55, 10958-10971
-
(2012)
J. Med. Chem.
, vol.55
, pp. 10958-10971
-
-
Koehler, M.F.T.1
Bergeron, P.2
Blackwood, E.3
Bowman, K.K.4
Chen, Y.-H.5
Deshmukh, G.6
Ding, X.7
Epler, J.8
Lau, K.9
Lee, L.10
Liu, L.11
Ly, C.12
Malek, S.13
Nonomiya, J.14
Oeh, J.15
Ortwine, D.F.16
Sampath, D.17
Sideris, S.18
Trinh, L.19
Truong, T.20
Wu, J.21
Pei, Z.22
Lyssikatos, J.P.23
more..
-
240
-
-
84872317017
-
Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349
-
Pei, Z.; Blackwood, E.; Liu, L.; Malek, S.; Belvin, M.; Koehler, M. F. T.; Ortwine, D. F.; Chen, H.; Cohen, F.; Kenny, J. R.; Bergeron, P.; Lau, K.; Ly, C.; Zhao, X.; Estrada, A. A.; Truong, T.; Epler, J. A.; Nonomiya, J.; Trinh, L.; Sideris, S.; Lesnick, J.; Bao, L.; Vijapurkar, U.; Mukadam, S.; Tay, S.; Deshmukh, G.; Chen, Y.-H.; Ding, X.; Friedman, L. S.; Lyssikatos, J. P. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349 ACS Med. Chem. Lett. 2013, 4, 103-107
-
(2013)
ACS Med. Chem. Lett.
, vol.4
, pp. 103-107
-
-
Pei, Z.1
Blackwood, E.2
Liu, L.3
Malek, S.4
Belvin, M.5
Koehler, M.F.T.6
Ortwine, D.F.7
Chen, H.8
Cohen, F.9
Kenny, J.R.10
Bergeron, P.11
Lau, K.12
Ly, C.13
Zhao, X.14
Estrada, A.A.15
Truong, T.16
Epler, J.A.17
Nonomiya, J.18
Trinh, L.19
Sideris, S.20
Lesnick, J.21
Bao, L.22
Vijapurkar, U.23
Mukadam, S.24
Tay, S.25
Deshmukh, G.26
Chen, Y.-H.27
Ding, X.28
Friedman, L.S.29
Lyssikatos, J.P.30
more..
-
241
-
-
73249140565
-
Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors
-
Zask, A.; Kaplan, J.; Verheijen, J. C.; Richard, D. J.; Curran, K.; Brooijmans, N.; Bennett, E. M.; Toral-Barza, L.; Hollander, I.; Ayral-Kaloustian, S.; Yu, K. Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors J. Med. Chem. 2009, 52, 7942-7945
-
(2009)
J. Med. Chem.
, vol.52
, pp. 7942-7945
-
-
Zask, A.1
Kaplan, J.2
Verheijen, J.C.3
Richard, D.J.4
Curran, K.5
Brooijmans, N.6
Bennett, E.M.7
Toral-Barza, L.8
Hollander, I.9
Ayral-Kaloustian, S.10
Yu, K.11
-
242
-
-
71849089048
-
Incorporation of Water-Solubilizing Groups in Pyrazolopyrimidine mTOR Inhibitors: Discovery of Highly Potent and Selective Analogs with Improved Human Microsomal Stability
-
Richard, D. J.; Verheijen, J. C.; Curran, K.; Kaplan, J.; Toral-Barza, L.; Hollander, I.; Lucas, J.; Yu, K.; Zask, A. Incorporation of Water-Solubilizing Groups in Pyrazolopyrimidine mTOR Inhibitors: Discovery of Highly Potent and Selective Analogs with Improved Human Microsomal Stability Bioorg. Med. Chem. Lett. 2009, 19, 6830-6835
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 6830-6835
-
-
Richard, D.J.1
Verheijen, J.C.2
Curran, K.3
Kaplan, J.4
Toral-Barza, L.5
Hollander, I.6
Lucas, J.7
Yu, K.8
Zask, A.9
-
243
-
-
72049122106
-
Discovery of 2-Arylthieno[3,2- d ]pyrimidines Containing 8-Oxa-3-azabicyclo[3.2.1]octane in the 4-Position as Potent Inhibitors of mTOR with Selectivity over PI3K
-
Verheijen, J. C.; Yu, K.; Toral-Barza, L.; Hollander, I.; Zask, A. Discovery of 2-Arylthieno[3,2- d ]pyrimidines Containing 8-Oxa-3-azabicyclo[3.2.1]octane in the 4-Position as Potent Inhibitors of mTOR with Selectivity over PI3K Bioorg. Med. Chem. Lett. 2010, 20, 375-379
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 375-379
-
-
Verheijen, J.C.1
Yu, K.2
Toral-Barza, L.3
Hollander, I.4
Zask, A.5
-
244
-
-
77950055909
-
Discovery of 2-Ureidophenyltriazines Bearing Bridged Morpholines as Potent and Selective ATP-Competitive mTOR Inhibitors
-
Zask, A.; Verheijen, J. C.; Richard, D. J.; Kaplan, J.; Curran, K.; Toral-Barza, L.; Lucas, J.; Hollander, I.; Yu, K. Discovery of 2-Ureidophenyltriazines Bearing Bridged Morpholines as Potent and Selective ATP-Competitive mTOR Inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 2644-2647
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 2644-2647
-
-
Zask, A.1
Verheijen, J.C.2
Richard, D.J.3
Kaplan, J.4
Curran, K.5
Toral-Barza, L.6
Lucas, J.7
Hollander, I.8
Yu, K.9
-
245
-
-
72249090391
-
Discovery of 3,6-Dihydro-2 H -pyran as a Morpholine Replacement in 6-Aryl-1 H -pyrazolo[3,4- d ]pyrimidines and 2-Arylthieno[3,2- d ]pyrimidines: ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR)
-
Kaplan, J.; Verheijen, J. C.; Brooijmans, N.; Toral-Barza, L.; Hollander, I.; Yu, K.; Zask, A. Discovery of 3,6-Dihydro-2 H -pyran as a Morpholine Replacement in 6-Aryl-1 H -pyrazolo[3,4- d ]pyrimidines and 2-Arylthieno[3,2- d ]pyrimidines: ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR) Bioorg. Med. Chem. Lett. 2010, 20, 640-643
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 640-643
-
-
Kaplan, J.1
Verheijen, J.C.2
Brooijmans, N.3
Toral-Barza, L.4
Hollander, I.5
Yu, K.6
Zask, A.7
-
247
-
-
84875143334
-
Discovery of 4-{4-[(3 R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1 H -indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity
-
Foote, K. M.; Blades, K.; Cronin, A.; Fillery, S.; Guichard, S. S.; Hassall, L.; Hickson, I.; Jacq, X.; Jewsbury, P. J.; McGuire, T. M.; Nissink, J. W. M.; Odedra, R.; Page, K.; Perkins, P.; Suleman, A.; Tam, K.; Thommes, P.; Broadhurst, R.; Wood, C. Discovery of 4-{4-[(3 R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1 H -indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity J. Med. Chem. 2013, 56, 2125-2138
-
(2013)
J. Med. Chem.
, vol.56
, pp. 2125-2138
-
-
Foote, K.M.1
Blades, K.2
Cronin, A.3
Fillery, S.4
Guichard, S.S.5
Hassall, L.6
Hickson, I.7
Jacq, X.8
Jewsbury, P.J.9
McGuire, T.M.10
Nissink, J.W.M.11
Odedra, R.12
Page, K.13
Perkins, P.14
Suleman, A.15
Tam, K.16
Thommes, P.17
Broadhurst, R.18
Wood, C.19
-
248
-
-
84899440993
-
Discovery of AZD6738, a Potent and Selective Inhibitor with the Potential to Test the Clinical Efficacy of ATR Kinase Inhibition in Cancer Patients
-
(Proceedings of American Association for Cancer Research, 104th Annual Meeting, Washington DC, Apr 6-10 2013).
-
Jones, C. D.; Blades, K.; Foote, K. M.; Guichard, S. M.; Jewsbury, P. J.; McGuire, T.; Nissink, J. W.; Odedra, R.; Tam, K.; Thommes, P.; Turner, P.; Wilkinson, G.; Wood, C.; Yates, J. W. Discovery of AZD6738, a Potent and Selective Inhibitor with the Potential To Test the Clinical Efficacy of ATR Kinase Inhibition in Cancer Patients. (Proceedings of American Association for Cancer Research, 104th Annual Meeting, Washington DC, Apr 6-10 2013) Cancer Res. 2013, 73, Abstract 2348.
-
(2013)
Cancer Res.
, vol.73
, pp. 2348
-
-
Jones, C.D.1
Blades, K.2
Foote, K.M.3
Guichard, S.M.4
Jewsbury, P.J.5
McGuire, T.6
Nissink, J.W.7
Odedra, R.8
Tam, K.9
Thommes, P.10
Turner, P.11
Wilkinson, G.12
Wood, C.13
Yates, J.W.14
-
249
-
-
84920963201
-
The Pre-Clinical in Vitro and in Vivo Activity of AZD6738: A Potent and Selective Inhibitor of ATR Kinase
-
(Proceedings of American Association for Cancer Research, 104th Annual Meeting, Washington DC, Apr 6-10 2013).
-
Guichard, S. M.; Brown, E.; Odedra, R.; Hughes, A.; Heathcote, D.; Barnes, J.; Lau, A.; Powell, S.; Jones, C. D.; Nissink, W.; Foote, K. M.; Jewsbury, P. J.; Pass, M. The Pre-Clinical in Vitro and in Vivo Activity of AZD6738: A Potent and Selective Inhibitor of ATR Kinase. (Proceedings of American Association for Cancer Research, 104th Annual Meeting, Washington DC, Apr 6-10 2013) Cancer Res. 2013, 73, Abstract 3343.
-
(2013)
Cancer Res.
, vol.73
, pp. 3343
-
-
Guichard, S.M.1
Brown, E.2
Odedra, R.3
Hughes, A.4
Heathcote, D.5
Barnes, J.6
Lau, A.7
Powell, S.8
Jones, C.D.9
Nissink, W.10
Foote, K.M.11
Jewsbury, P.J.12
Pass, M.13
-
250
-
-
78751553221
-
CAL-101, a p110delta Selective Phosphatidylinositol-3-kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability
-
Lannutti, B. J.; Meadows, S. A.; Herman, S. E. M.; Kashishian, A.; Steiner, B.; Johnson, A. J.; Byrd, J. C.; Tyner, J. W.; Loriaux, M. M.; Deininger, M.; Druker, B. J.; Puri, K. D.; Ulrich, R. G.; Giese, N. A. CAL-101, a p110delta Selective Phosphatidylinositol-3-kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability Blood 2011, 117, 591-594
-
(2011)
Blood
, vol.117
, pp. 591-594
-
-
Lannutti, B.J.1
Meadows, S.A.2
Herman, S.E.M.3
Kashishian, A.4
Steiner, B.5
Johnson, A.J.6
Byrd, J.C.7
Tyner, J.W.8
Loriaux, M.M.9
Deininger, M.10
Druker, B.J.11
Puri, K.D.12
Ulrich, R.G.13
Giese, N.A.14
-
251
-
-
84888219144
-
PI3K- and PI3K- Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models
-
Winkler, D. G.; Faia, K. L.; DiNitto, J. P.; Ali, J. A.; White, K. F.; Brophy, E. E.; Pink, M. M.; Proctor, J. L.; Lussier, J.; Martin, C. M.; Hoyt, J. G.; Tillotson, B.; Murphy, E. L.; Lim, A. R.; Thomas, B. D.; Macdougall, J. R.; Ren, P.; Liu, Y.; Li, L.-S.; Jessen, K. A.; Fritz, C. C.; Dunbar, J. L.; Porter, J. R.; Rommel, C.; Palombella, V. J.; Changelian, P. S.; Kutok, J. L. PI3K- and PI3K- Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models Chem. Biol. 2013, 20, 1364-1374
-
(2013)
Chem. Biol.
, vol.20
, pp. 1364-1374
-
-
Winkler, D.G.1
Faia, K.L.2
Dinitto, J.P.3
Ali, J.A.4
White, K.F.5
Brophy, E.E.6
Pink, M.M.7
Proctor, J.L.8
Lussier, J.9
Martin, C.M.10
Hoyt, J.G.11
Tillotson, B.12
Murphy, E.L.13
Lim, A.R.14
Thomas, B.D.15
Macdougall, J.R.16
Ren, P.17
Liu, Y.18
Li, L.-S.19
Jessen, K.A.20
Fritz, C.C.21
Dunbar, J.L.22
Porter, J.R.23
Rommel, C.24
Palombella, V.J.25
Changelian, P.S.26
Kutok, J.L.27
more..
-
252
-
-
84865805718
-
Two Hits Are Better Than One: Targeting Both Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a Therapeutic Strategy for Acute Leukemia Treatment
-
Martelli, A. M.; Chiarini, F.; Evangelisti, C.; Cappellini, A.; Buontempo, F.; Bressanin, D.; Fini, M.; McCubrey, J. A. Two Hits Are Better Than One: Targeting Both Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a Therapeutic Strategy for Acute Leukemia Treatment Oncotarget 2012, 3, 371-394
-
(2012)
Oncotarget
, vol.3
, pp. 371-394
-
-
Martelli, A.M.1
Chiarini, F.2
Evangelisti, C.3
Cappellini, A.4
Buontempo, F.5
Bressanin, D.6
Fini, M.7
McCubrey, J.A.8
-
253
-
-
79958011128
-
Role of Dual PI3/Akt and mTOR Inhibition in Waldenstroms Macroglobulinemia
-
Sacco, A.; Roccaro, A.; Ghobrial, I. M. Role of Dual PI3/Akt and mTOR Inhibition in Waldenstroms Macroglobulinemia Oncotarget 2010, 1, 578-582
-
(2010)
Oncotarget
, vol.1
, pp. 578-582
-
-
Sacco, A.1
Roccaro, A.2
Ghobrial, I.M.3
-
254
-
-
35248889546
-
The Therapeutic Potential of O6-Alkylguanine DNA Alkyltransferase Inhibitors
-
Khan, O.; Middleton, M. R. The Therapeutic Potential of O6-Alkylguanine DNA Alkyltransferase Inhibitors Expert Opin. Invest. Drugs 2007, 16, 1573-1584
-
(2007)
Expert Opin. Invest. Drugs
, vol.16
, pp. 1573-1584
-
-
Khan, O.1
Middleton, M.R.2
-
255
-
-
79651470785
-
Death by Releasing the Breaks: CHK1 Inhibitors as Cancer Therapeutics
-
Ma, C. X.; Janetka, J. W.; Piwnica-Worms, H. Death by Releasing the Breaks: CHK1 Inhibitors as Cancer Therapeutics Trends Mol. Med. 2011, 17, 88-96
-
(2011)
Trends Mol. Med.
, vol.17
, pp. 88-96
-
-
Ma, C.X.1
Janetka, J.W.2
Piwnica-Worms, H.3
|